id	sid	tid	token	lemma	pos
gra-2158	1	1	15.bluetree	15.bluetree	NUM
gra-2158	1	2	02.cdr	02.cdr	PROPN
gra-2158	1	3	type	type	NOUN
gra-2158	1	4	2	2	NUM
gra-2158	1	5	diabetic	diabetic	ADJ
gra-2158	1	6	patients	patient	NOUN
gra-2158	1	7	are	be	AUX
gra-2158	1	8	often	often	ADV
gra-2158	1	9	treated	treat	VERB
gra-2158	1	10	with	with	ADP
gra-2158	1	11	a	a	DET
gra-2158	1	12	combination	combination	NOUN
gra-2158	1	13	of	of	ADP
gra-2158	1	14	antidiabetic	antidiabetic	ADJ
gra-2158	1	15	agents	agent	NOUN
gra-2158	1	16	.	.	PUNCT
gra-2158	2	1	the	the	DET
gra-2158	2	2	need	need	NOUN
gra-2158	2	3	to	to	PART
gra-2158	2	4	use	use	VERB
gra-2158	2	5	drugs	drug	NOUN
gra-2158	2	6	with	with	ADP
gra-2158	2	7	different	different	ADJ
gra-2158	2	8	and	and	CCONJ
gra-2158	2	9	complementary	complementary	ADJ
gra-2158	2	10	mechanisms	mechanism	NOUN
gra-2158	2	11	of	of	ADP
gra-2158	2	12	action	action	NOUN
gra-2158	2	13	frequently	frequently	ADV
gra-2158	2	14	arises	arise	VERB
gra-2158	2	15	in	in	ADP
gra-2158	2	16	daily	daily	ADJ
gra-2158	2	17	clinical	clinical	ADJ
gra-2158	2	18	practice	practice	NOUN
gra-2158	2	19	.	.	PUNCT
gra-2158	3	1	there	there	PRON
gra-2158	3	2	are	be	VERB
gra-2158	3	3	several	several	ADJ
gra-2158	3	4	reasons	reason	NOUN
gra-2158	3	5	to	to	PART
gra-2158	3	6	do	do	VERB
gra-2158	3	7	this	this	PRON
gra-2158	3	8	;	;	PUNCT
gra-2158	3	9	namely	namely	ADV
gra-2158	3	10	,	,	PUNCT
gra-2158	3	11	the	the	DET
gra-2158	3	12	disease	disease	NOUN
gra-2158	3	13	itself	itself	PRON
gra-2158	3	14	is	be	AUX
gra-2158	3	15	progressive	progressive	ADJ
gra-2158	3	16	,	,	PUNCT
gra-2158	3	17	with	with	ADP
gra-2158	3	18	the	the	DET
gra-2158	3	19	deterioration	deterioration	NOUN
gra-2158	3	20	of	of	ADP
gra-2158	3	21	glycemic	glycemic	ADJ
gra-2158	3	22	control	control	NOUN
gra-2158	3	23	over	over	ADP
gra-2158	3	24	time	time	NOUN
gra-2158	3	25	,	,	PUNCT
gra-2158	3	26	and	and	CCONJ
gra-2158	3	27	monotherapeutic	monotherapeutic	ADJ
gra-2158	3	28	attempts	attempt	NOUN
gra-2158	3	29	to	to	PART
gra-2158	3	30	achieve	achieve	VERB
gra-2158	3	31	and	and	CCONJ
gra-2158	3	32	maintain	maintain	VERB
gra-2158	3	33	glycemic	glycemic	ADJ
gra-2158	3	34	control	control	NOUN
gra-2158	3	35	often	often	ADV
gra-2158	3	36	fail	fail	VERB
gra-2158	3	37	in	in	ADP
gra-2158	3	38	the	the	DET
gra-2158	3	39	long	long	ADJ
gra-2158	3	40	1run	1run	NUM
gra-2158	3	41	.	.	PUNCT
gra-2158	4	1	some	some	DET
gra-2158	4	2	patients	patient	NOUN
gra-2158	4	3	do	do	AUX
gra-2158	4	4	not	not	PART
gra-2158	4	5	accept	accept	VERB
gra-2158	4	6	insulin	insulin	NOUN
gra-2158	4	7	treatment	treatment	NOUN
gra-2158	4	8	because	because	SCONJ
gra-2158	4	9	of	of	ADP
gra-2158	4	10	the	the	DET
gra-2158	4	11	fear	fear	NOUN
gra-2158	4	12	of	of	ADP
gra-2158	4	13	needles	needle	NOUN
gra-2158	4	14	and	and	CCONJ
gra-2158	4	15	injections	injection	NOUN
gra-2158	4	16	,	,	PUNCT
gra-2158	4	17	the	the	DET
gra-2158	4	18	fear	fear	NOUN
gra-2158	4	19	that	that	SCONJ
gra-2158	4	20	the	the	DET
gra-2158	4	21	complications	complication	NOUN
gra-2158	4	22	of	of	ADP
gra-2158	4	23	diabetes	diabetes	NOUN
gra-2158	4	24	are	be	AUX
gra-2158	4	25	caused	cause	VERB
gra-2158	4	26	by	by	ADP
gra-2158	4	27	insulin	insulin	NOUN
gra-2158	4	28	,	,	PUNCT
gra-2158	4	29	and	and	CCONJ
gra-2158	4	30	other	other	ADJ
gra-2158	4	31	false	false	ADJ
gra-2158	4	32	beliefs	belief	NOUN
gra-2158	4	33	,	,	PUNCT
gra-2158	4	34	and	and	CCONJ
gra-2158	4	35	are	be	AUX
gra-2158	4	36	willing	willing	ADJ
gra-2158	4	37	to	to	PART
gra-2158	4	38	take	take	VERB
gra-2158	4	39	as	as	ADV
gra-2158	4	40	many	many	ADJ
gra-2158	4	41	anti	anti	ADJ
gra-2158	4	42	-	-	ADJ
gra-2158	4	43	diabetic	diabetic	ADJ
gra-2158	4	44	pills	pill	NOUN
gra-2158	4	45	.	.	PUNCT
gra-2158	5	1	several	several	ADJ
gra-2158	5	2	pharmacological	pharmacological	ADJ
gra-2158	5	3	agents	agent	NOUN
gra-2158	5	4	have	have	AUX
gra-2158	5	5	been	be	AUX
gra-2158	5	6	developed	develop	VERB
gra-2158	5	7	to	to	PART
gra-2158	5	8	treat	treat	VERB
gra-2158	5	9	patients	patient	NOUN
gra-2158	5	10	with	with	ADP
gra-2158	5	11	type	type	NOUN
gra-2158	5	12	2	2	NUM
gra-2158	5	13	diabetes	diabetes	NOUN
gra-2158	5	14	mellitus	mellitus	NOUN
gra-2158	5	15	.	.	PUNCT
gra-2158	6	1	they	they	PRON
gra-2158	6	2	either	either	CCONJ
gra-2158	6	3	improve	improve	VERB
gra-2158	6	4	insulin	insulin	NOUN
gra-2158	6	5	resistance	resistance	NOUN
gra-2158	6	6	(	(	PUNCT
gra-2158	6	7	biguanides	biguanide	NOUN
gra-2158	6	8	and	and	CCONJ
gra-2158	6	9	thiazolid	thiazolid	ADJ
gra-2158	6	10	ine	ine	PROPN
gra-2158	6	11	diones	dione	NOUN
gra-2158	6	12	)	)	PUNCT
gra-2158	6	13	,	,	PUNCT
gra-2158	6	14	stimulate	stimulate	VERB
gra-2158	6	15	insulin	insulin	NOUN
gra-2158	6	16	secretion	secretion	NOUN
gra-2158	6	17	from	from	ADP
gra-2158	6	18	the	the	DET
gra-2158	6	19	�	�	NOUN
gra-2158	6	20	-cell	-cell	NOUN
gra-2158	6	21	(	(	PUNCT
gra-2158	6	22	sulphonyl	sulphonyl	NOUN
gra-2158	6	23	ureas	urea	NOUN
gra-2158	6	24	and	and	CCONJ
gra-2158	6	25	metaglinides	metaglinide	NOUN
gra-2158	6	26	)	)	PUNCT
gra-2158	6	27	,	,	PUNCT
gra-2158	6	28	or	or	CCONJ
gra-2158	6	29	decrease	decrease	VERB
gra-2158	6	30	glucose	glucose	NOUN
gra-2158	6	31	absorption	absorption	NOUN
gra-2158	6	32	2from	2from	NUM
gra-2158	6	33	the	the	DET
gra-2158	6	34	gut	gut	NOUN
gra-2158	6	35	(	(	PUNCT
gra-2158	6	36	α	α	NOUN
gra-2158	6	37	-	-	PUNCT
gra-2158	6	38	glucosidase	glucosidase	ADJ
gra-2158	6	39	inhibitors	inhibitor	NOUN
gra-2158	6	40	)	)	PUNCT
gra-2158	6	41	.	.	PUNCT
gra-2158	7	1	metformin	metformin	NOUN
gra-2158	7	2	monot	monot	PROPN
gra-2158	7	3	he	he	PRON
gra-2158	7	4	rapy	rapy	PROPN
gra-2158	7	5	is	be	AUX
gra-2158	7	6	initially	initially	ADV
gra-2158	7	7	recommended	recommend	VERB
gra-2158	7	8	along	along	ADP
gra-2158	7	9	with	with	ADP
gra-2158	7	10	lifestyle	lifestyle	NOUN
gra-2158	7	11	modica	modica	PROPN
gra-2158	7	12	tions	tion	NOUN
gra-2158	7	13	(	(	PUNCT
gra-2158	7	14	increased	increase	VERB
gra-2158	7	15	physical	physical	ADJ
gra-2158	7	16	activity	activity	NOUN
gra-2158	7	17	and	and	CCONJ
gra-2158	7	18	weight	weight	NOUN
gra-2158	7	19	loss	loss	NOUN
gra-2158	7	20	)	)	PUNCT
gra-2158	7	21	for	for	ADP
gra-2158	7	22	glycemic	glycemic	ADJ
gra-2158	7	23	management	management	NOUN
gra-2158	7	24	of	of	ADP
gra-2158	7	25	type	type	NOUN
gra-2158	7	26	2	2	NUM
gra-2158	7	27	dm	dm	NOUN
gra-2158	7	28	.	.	PUNCT
gra-2158	8	1	however	however	ADV
gra-2158	8	2	,	,	PUNCT
gra-2158	8	3	if	if	SCONJ
gra-2158	8	4	glucose	glucose	NOUN
gra-2158	8	5	levels	level	NOUN
gra-2158	8	6	are	be	AUX
gra-2158	8	7	not	not	PART
gra-2158	8	8	controlled	control	VERB
gra-2158	8	9	in	in	ADP
gra-2158	8	10	patients	patient	NOUN
gra-2158	8	11	with	with	ADP
gra-2158	8	12	type	type	NOUN
gra-2158	8	13	2	2	NUM
gra-2158	8	14	diabetes	diabete	NOUN
gra-2158	8	15	,	,	PUNCT
gra-2158	8	16	other	other	ADJ
gra-2158	8	17	classes	class	NOUN
gra-2158	8	18	of	of	ADP
gra-2158	8	19	antidiabetic	antidiabetic	ADJ
gra-2158	8	20	agents	agent	NOUN
gra-2158	8	21	are	be	AUX
gra-2158	8	22	then	then	ADV
gra-2158	8	23	additionally	additionally	ADV
gra-2158	8	24	required	require	VERB
gra-2158	8	25	.	.	PUNCT
gra-2158	9	1	coadministration	coadministration	NOUN
gra-2158	9	2	of	of	ADP
gra-2158	9	3	glimepiride	glimepiride	NOUN
gra-2158	9	4	and	and	CCONJ
gra-2158	9	5	metformin	metformin	NOUN
gra-2158	9	6	has	have	AUX
gra-2158	9	7	been	be	AUX
gra-2158	9	8	3used	3use	VERB
gra-2158	9	9	to	to	PART
gra-2158	9	10	achieve	achieve	VERB
gra-2158	9	11	glucose	glucose	NOUN
gra-2158	9	12	control	control	NOUN
gra-2158	9	13	.	.	PUNCT
gra-2158	10	1	combination	combination	NOUN
gra-2158	10	2	therapy	therapy	NOUN
gra-2158	10	3	using	use	VERB
gra-2158	10	4	sulfonylurea	sulfonylurea	NOUN
gra-2158	10	5	and	and	CCONJ
gra-2158	10	6	metformin	metformin	NOUN
gra-2158	10	7	,	,	PUNCT
gra-2158	10	8	which	which	PRON
gra-2158	10	9	respectively	respectively	ADV
gra-2158	10	10	promotes	promote	VERB
gra-2158	10	11	insulin	insulin	NOUN
gra-2158	10	12	secretion	secretion	NOUN
gra-2158	10	13	and	and	CCONJ
gra-2158	10	14	improves	improve	VERB
gra-2158	10	15	insulin	insulin	NOUN
gra-2158	10	16	resistance	resistance	NOUN
gra-2158	10	17	,	,	PUNCT
gra-2158	10	18	is	be	AUX
gra-2158	10	19	an	an	DET
gra-2158	10	20	effective	effective	ADJ
gra-2158	10	21	and	and	CCONJ
gra-2158	10	22	complementary	complementary	ADJ
gra-2158	10	23	method	method	NOUN
gra-2158	10	24	that	that	PRON
gra-2158	10	25	improves	improve	VERB
gra-2158	10	26	both	both	PRON
gra-2158	10	27	of	of	ADP
gra-2158	10	28	the	the	DET
gra-2158	10	29	main	main	ADJ
gra-2158	10	30	causes	cause	NOUN
gra-2158	10	31	of	of	ADP
gra-2158	10	32	type	type	NOUN
gra-2158	10	33	2	2	NUM
gra-2158	10	34	diabetes	diabetes	NOUN
gra-2158	10	35	and	and	CCONJ
gra-2158	10	36	has	have	AUX
gra-2158	10	37	been	be	AUX
gra-2158	10	38	reported	report	VERB
gra-2158	10	39	by	by	ADP
gra-2158	10	40	ukpds	ukpds	PROPN
gra-2158	10	41	and	and	CCONJ
gra-2158	10	42	other	other	ADJ
gra-2158	10	43	clinical	clinical	ADJ
gra-2158	10	44	studies	study	NOUN
gra-2158	10	45	to	to	PART
gra-2158	10	46	be	be	AUX
gra-2158	10	47	4more	4more	NUM
gra-2158	10	48	effective	effective	ADJ
gra-2158	10	49	than	than	ADP
gra-2158	10	50	monotherapy	monotherapy	NOUN
gra-2158	10	51	of	of	ADP
gra-2158	10	52	both	both	DET
gra-2158	10	53	drugs	drug	NOUN
gra-2158	10	54	.	.	PUNCT
gra-2158	11	1	metformin	metformin	NOUN
gra-2158	11	2	improves	improve	VERB
gra-2158	11	3	insulin	insulin	NOUN
gra-2158	11	4	resistance	resistance	NOUN
gra-2158	11	5	and	and	CCONJ
gra-2158	11	6	is	be	AUX
gra-2158	11	7	recommended	recommend	VERB
gra-2158	11	8	as	as	ADP
gra-2158	11	9	the	the	DET
gra-2158	11	10	rstchoice	rstchoice	NOUN
gra-2158	11	11	medication	medication	NOUN
gra-2158	11	12	for	for	ADP
gra-2158	11	13	newly	newly	ADV
gra-2158	11	14	diagnosed	diagnose	VERB
gra-2158	11	15	type	type	NOUN
gra-2158	11	16	2	2	NUM
gra-2158	11	17	diabetes	diabetes	NOUN
gra-2158	11	18	patients	patient	NOUN
gra-2158	11	19	by	by	ADP
gra-2158	11	20	most	most	ADJ
gra-2158	11	21	guidelines	guideline	NOUN
gra-2158	11	22	.	.	PUNCT
gra-2158	12	1	glimepiride	glimepiride	NOUN
gra-2158	12	2	is	be	AUX
gra-2158	12	3	a	a	DET
gra-2158	12	4	third	third	ADJ
gra-2158	12	5	-	-	PUNCT
gra-2158	12	6	generation	generation	NOUN
gra-2158	12	7	sulfonylurea	sulfonylurea	NOUN
gra-2158	12	8	that	that	PRON
gra-2158	12	9	stimulates	stimulate	VERB
gra-2158	12	10	insulin	insulin	NOUN
gra-2158	12	11	secretion	secretion	NOUN
gra-2158	12	12	.	.	PUNCT
gra-2158	13	1	unlike	unlike	ADP
gra-2158	13	2	conventional	conventional	ADJ
gra-2158	13	3	sulfonylurea	sulfonylurea	NOUN
gra-2158	13	4	,	,	PUNCT
gra-2158	13	5	glimepiride	glimepiride	NOUN
gra-2158	13	6	has	have	VERB
gra-2158	13	7	high	high	ADJ
gra-2158	13	8	selectivity	selectivity	NOUN
gra-2158	13	9	toward	toward	ADP
gra-2158	13	10	the	the	DET
gra-2158	13	11	pancreatic	pancreatic	ADJ
gra-2158	13	12	atp	atp	PROPN
gra-2158	13	13	-	-	PUNCT
gra-2158	13	14	sensitive	sensitive	ADJ
gra-2158	13	15	potassium	potassium	NOUN
gra-2158	13	16	channel	channel	NOUN
gra-2158	13	17	,	,	PUNCT
gra-2158	13	18	increases	increase	VERB
gra-2158	13	19	glucose	glucose	NOUN
gra-2158	13	20	t	t	PROPN
gra-2158	13	21	ranspor	ranspor	PROPN
gra-2158	13	22	t	t	PROPN
gra-2158	13	23	,	,	PUNCT
gra-2158	13	24	and	and	CCONJ
gra-2158	13	25	shows	show	VERB
gra-2158	13	26	var	var	VERB
gra-2158	13	27	ious	ious	ADJ
gra-2158	13	28	extrapancreatic	extrapancreatic	ADJ
gra-2158	13	29	effects	effect	NOUN
gra-2158	13	30	in	in	ADP
gra-2158	13	31	muscle	muscle	NOUN
gra-2158	13	32	and	and	CCONJ
gra-2158	13	33	fat	fat	ADJ
gra-2158	13	34	cells	cell	NOUN
gra-2158	13	35	.	.	PUNCT
gra-2158	14	1	for	for	ADP
gra-2158	14	2	these	these	DET
gra-2158	14	3	benets	benets	PROPN
gra-2158	14	4	,	,	PUNCT
gra-2158	14	5	glimepiride	glimepiride	NOUN
gra-2158	14	6	is	be	AUX
gra-2158	14	7	prescribed	prescribe	VERB
gra-2158	14	8	as	as	ADP
gra-2158	14	9	a	a	DET
gra-2158	14	10	primary	primary	ADJ
gra-2158	14	11	monotherapy	monotherapy	NOUN
gra-2158	14	12	or	or	CCONJ
gra-2158	14	13	additional	additional	ADJ
gra-2158	14	14	medication	medication	NOUN
gra-2158	14	15	when	when	SCONJ
gra-2158	14	16	metformin	metformin	NOUN
gra-2158	14	17	monotherapy	monotherapy	NOUN
gra-2158	14	18	has	have	AUX
gra-2158	14	19	failed	fail	VERB
gra-2158	14	20	.	.	PUNCT
gra-2158	15	1	various	various	ADJ
gra-2158	15	2	trials	trial	NOUN
gra-2158	15	3	have	have	AUX
gra-2158	15	4	established	establish	VERB
gra-2158	15	5	the	the	DET
gra-2158	15	6	efcacy	efcacy	NOUN
gra-2158	15	7	of	of	ADP
gra-2158	15	8	the	the	DET
gra-2158	15	9	combination	combination	NOUN
gra-2158	15	10	of	of	ADP
gra-2158	15	11	metformin	metformin	NOUN
gra-2158	15	12	with	with	ADP
gra-2158	15	13	glimepiride	glimepiride	NOUN
gra-2158	15	14	.	.	PUNCT
gra-2158	16	1	kim	kim	PROPN
gra-2158	16	2	et	et	PROPN
gra-2158	16	3	al	al	PROPN
gra-2158	16	4	.	.	PROPN
gra-2158	16	5	compared	compare	VERB
gra-2158	16	6	the	the	DET
gra-2158	16	7	efcacy	efcacy	NOUN
gra-2158	16	8	and	and	CCONJ
gra-2158	16	9	safety	safety	NOUN
gra-2158	16	10	of	of	ADP
gra-2158	16	11	early	early	ADJ
gra-2158	16	12	combination	combination	NOUN
gra-2158	16	13	therapy	therapy	NOUN
gra-2158	16	14	with	with	ADP
gra-2158	16	15	glimepiride	glimepiride	NOUN
gra-2158	16	16	/	/	SYM
gra-2158	16	17	metformin	metformin	NOUN
gra-2158	16	18	to	to	PART
gra-2158	16	19	metformin	metformin	VERB
gra-2158	16	20	up	up	ADP
gra-2158	16	21	-	-	PUNCT
gra-2158	16	22	titration	titration	NOUN
gra-2158	16	23	in	in	ADP
gra-2158	16	24	reducing	reduce	VERB
gra-2158	16	25	glycated	glycate	VERB
gra-2158	16	26	hemoglobin	hemoglobin	NOUN
gra-2158	16	27	(	(	PUNCT
gra-2158	16	28	hba1c	hba1c	NOUN
gra-2158	16	29	)	)	PUNCT
gra-2158	16	30	levels	level	NOUN
gra-2158	16	31	in	in	ADP
gra-2158	16	32	korean	korean	ADJ
gra-2158	16	33	type	type	NOUN
gra-2158	16	34	2	2	NUM
gra-2158	16	35	diabetic	diabetic	ADJ
gra-2158	16	36	patients	patient	NOUN
gra-2158	16	37	inadequately	inadequately	ADV
gra-2158	16	38	controlled	control	VERB
gra-2158	16	39	on	on	ADP
gra-2158	16	40	low	low	ADJ
gra-2158	16	41	-	-	PUNCT
gra-2158	16	42	dose	dose	NOUN
gra-2158	16	43	metformin	metformin	NOUN
gra-2158	16	44	monotherapy	monotherapy	NOUN
gra-2158	16	45	.	.	PUNCT
gra-2158	17	1	the	the	DET
gra-2158	17	2	study	study	NOUN
gra-2158	17	3	was	be	AUX
gra-2158	17	4	a	a	DET
gra-2158	17	5	randomized	randomized	ADJ
gra-2158	17	6	,	,	PUNCT
gra-2158	17	7	openlabel	openlabel	NOUN
gra-2158	17	8	,	,	PUNCT
gra-2158	17	9	parallel	parallel	NOUN
gra-2158	17	10	-	-	PUNCT
gra-2158	17	11	group	group	NOUN
gra-2158	17	12	,	,	PUNCT
gra-2158	17	13	multicenter	multicenter	NOUN
gra-2158	17	14	study	study	NOUN
gra-2158	17	15	,	,	PUNCT
gra-2158	17	16	209	209	NUM
gra-2158	17	17	korean	korean	ADJ
gra-2158	17	18	type	type	NOUN
gra-2158	17	19	2	2	NUM
gra-2158	17	20	diabetic	diabetic	ADJ
gra-2158	17	21	patients	patient	NOUN
gra-2158	17	22	(	(	PUNCT
gra-2158	17	23	hba1c	hba1c	NOUN
gra-2158	18	1	7.0–10.0	7.0–10.0	NUM
gra-2158	18	2	%	%	NOUN
gra-2158	18	3	,	,	PUNCT
gra-2158	18	4	on	on	ADP
gra-2158	18	5	metformin	metformin	NOUN
gra-2158	18	6	500–1,000	500–1,000	NUM
gra-2158	18	7	mg	mg	NUM
gra-2158	18	8	/	/	SYM
gra-2158	18	9	day	day	NOUN
gra-2158	18	10	)	)	PUNCT
gra-2158	18	11	received	receive	VERB
gra-2158	18	12	glimepiride	glimepiride	NOUN
gra-2158	18	13	/	/	SYM
gra-2158	18	14	metformin	metformin	NOUN
gra-2158	18	15	xed	xe	VERB
gra-2158	18	16	-	-	PUNCT
gra-2158	18	17	dose	dose	NOUN
gra-2158	18	18	combination	combination	NOUN
gra-2158	18	19	(	(	PUNCT
gra-2158	18	20	g	g	NOUN
gra-2158	18	21	/	/	SYM
gra-2158	18	22	m	m	VERB
gra-2158	18	23	fdc	fdc	PROPN
gra-2158	18	24	)	)	PUNCT
gra-2158	18	25	or	or	CCONJ
gra-2158	18	26	metformin	metformin	NOUN
gra-2158	18	27	uptitration	uptitration	NOUN
gra-2158	18	28	treatment	treatment	NOUN
gra-2158	18	29	(	(	PUNCT
gra-2158	18	30	met	meet	VERB
gra-2158	18	31	up	up	ADP
gra-2158	18	32	)	)	PUNCT
gra-2158	18	33	.	.	PUNCT
gra-2158	19	1	the	the	DET
gra-2158	19	2	primary	primary	ADJ
gra-2158	19	3	end	end	NOUN
gra-2158	19	4	-	-	PUNCT
gra-2158	19	5	point	point	NOUN
gra-2158	19	6	was	be	AUX
gra-2158	19	7	the	the	DET
gra-2158	19	8	change	change	NOUN
gra-2158	19	9	in	in	ADP
gra-2158	19	10	hba1c	hba1c	PROPN
gra-2158	19	11	from	from	ADP
gra-2158	19	12	baseline	baseline	NOUN
gra-2158	19	13	to	to	ADP
gra-2158	19	14	week	week	NOUN
gra-2158	19	15	24	24	NUM
gra-2158	19	16	.	.	PUNCT
gra-2158	20	1	g	g	NOUN
gra-2158	20	2	/	/	SYM
gra-2158	20	3	m	m	VERB
gra-2158	20	4	fdc	fdc	PROPN
gra-2158	20	5	therapy	therapy	NOUN
gra-2158	20	6	provided	provide	VERB
gra-2158	20	7	signicantly	signicantly	ADV
gra-2158	20	8	greater	greater	ADV
gra-2158	20	9	adjusted	adjust	VERB
gra-2158	20	10	mean	mean	NOUN
gra-2158	20	11	decreases	decrease	NOUN
gra-2158	20	12	vs	vs	ADP
gra-2158	20	13	met	meet	VERB
gra-2158	20	14	up	up	ADP
gra-2158	20	15	therapy	therapy	NOUN
gra-2158	20	16	in	in	ADP
gra-2158	20	17	hba1c	hba1c	PROPN
gra-2158	20	18	(	(	PUNCT
gra-2158	20	19	-1.2	-1.2	NOUN
gra-2158	20	20	vs	vs	ADP
gra-2158	20	21	-0.8	-0.8	ADJ
gra-2158	20	22	%	%	NOUN
gra-2158	20	23	,	,	PUNCT
gra-2158	20	24	p	p	X
gra-2158	20	25	<	<	X
gra-2158	20	26	0.0001	0.0001	NUM
gra-2158	20	27	)	)	PUNCT
gra-2158	20	28	,	,	PUNCT
gra-2158	20	29	and	and	CCONJ
gra-2158	20	30	fasting	fast	VERB
gra-2158	20	31	plasma	plasma	NOUN
gra-2158	20	32	glucose	glucose	NOUN
gra-2158	20	33	(	(	PUNCT
gra-2158	20	34	-35.7	-35.7	NOUN
gra-2158	20	35	vs	vs	ADP
gra-2158	20	36	-18.6	-18.6	ADJ
gra-2158	20	37	mg	mg	PROPN
gra-2158	20	38	/	/	SYM
gra-2158	20	39	dl	dl	PROPN
gra-2158	20	40	,	,	PUNCT
gra-2158	20	41	p	p	X
gra-2158	20	42	<	<	X
gra-2158	20	43	0.0001	0.0001	NUM
gra-2158	20	44	)	)	PUNCT
gra-2158	20	45	.	.	PUNCT
gra-2158	21	1	a	a	DET
gra-2158	21	2	signicantly	signicantly	ADV
gra-2158	21	3	greater	great	ADJ
gra-2158	21	4	proportion	proportion	NOUN
gra-2158	21	5	of	of	ADP
gra-2158	21	6	patients	patient	NOUN
gra-2158	21	7	with	with	ADP
gra-2158	21	8	g	g	PROPN
gra-2158	21	9	/	/	SYM
gra-2158	21	10	m	m	VERB
gra-2158	21	11	fdc	fdc	PROPN
gra-2158	21	12	therapy	therapy	NOUN
gra-2158	21	13	achieved	achieve	VERB
gra-2158	21	14	hba1c	hba1c	PROPN
gra-2158	21	15	<	<	X
gra-2158	21	16	7	7	NUM
gra-2158	21	17	%	%	NOUN
gra-2158	21	18	(	(	PUNCT
gra-2158	21	19	74.7	74.7	NUM
gra-2158	21	20	vs	vs	ADP
gra-2158	21	21	46.6	46.6	NUM
gra-2158	21	22	%	%	NOUN
gra-2158	21	23	,	,	PUNCT
gra-2158	21	24	p	p	X
gra-2158	21	25	<	<	X
gra-2158	21	26	0.0001	0.0001	NUM
gra-2158	21	27	)	)	PUNCT
gra-2158	21	28	at	at	ADP
gra-2158	21	29	the	the	DET
gra-2158	21	30	end	end	NOUN
gra-2158	21	31	of	of	ADP
gra-2158	21	32	the	the	DET
gra-2158	21	33	study	study	NOUN
gra-2158	21	34	.	.	PUNCT
gra-2158	22	1	a	a	DET
gra-2158	22	2	modest	modest	ADJ
gra-2158	22	3	increase	increase	NOUN
gra-2158	22	4	in	in	ADP
gra-2158	22	5	mean	mean	ADJ
gra-2158	22	6	body	body	NOUN
gra-2158	22	7	weight	weight	NOUN
gra-2158	22	8	occurred	occur	VERB
gra-2158	22	9	in	in	ADP
gra-2158	22	10	the	the	DET
gra-2158	22	11	patients	patient	NOUN
gra-2158	22	12	who	who	PRON
gra-2158	22	13	were	be	AUX
gra-2158	22	14	treated	treat	VERB
gra-2158	22	15	with	with	ADP
gra-2158	22	16	g	g	PROPN
gra-2158	22	17	/	/	SYM
gra-2158	22	18	m	m	PROPN
gra-2158	22	19	fdc	fdc	PROPN
gra-2158	22	20	therapy	therapy	NOUN
gra-2158	22	21	(	(	PUNCT
gra-2158	22	22	1.0	1.0	NUM
gra-2158	22	23	kg	kg	NOUN
gra-2158	22	24	)	)	PUNCT
gra-2158	22	25	,	,	PUNCT
gra-2158	22	26	whereas	whereas	SCONJ
gra-2158	22	27	a	a	DET
gra-2158	22	28	slight	slight	ADJ
gra-2158	22	29	decrease	decrease	NOUN
gra-2158	22	30	was	be	AUX
gra-2158	22	31	observed	observe	VERB
gra-2158	22	32	in	in	ADP
gra-2158	22	33	the	the	DET
gra-2158	22	34	patients	patient	NOUN
gra-2158	22	35	who	who	PRON
gra-2158	22	36	were	be	AUX
gra-2158	22	37	treated	treat	VERB
gra-2158	22	38	with	with	ADP
gra-2158	22	39	met	meet	VERB
gra-2158	22	40	up	up	ADP
gra-2158	22	41	therapy	therapy	NOUN
gra-2158	22	42	(	(	PUNCT
gra-2158	22	43	-0.7	-0.7	PROPN
gra-2158	22	44	kg	kg	PROPN
gra-2158	22	45	)	)	PUNCT
gra-2158	22	46	.	.	PUNCT
gra-2158	23	1	it	it	PRON
gra-2158	23	2	was	be	AUX
gra-2158	23	3	concluded	conclude	VERB
gra-2158	23	4	that	that	SCONJ
gra-2158	23	5	glimepiride	glimepiride	NOUN
gra-2158	23	6	/	/	SYM
gra-2158	23	7	metformin	metformin	NOUN
gra-2158	23	8	xed	xe	VERB
gra-2158	23	9	-	-	PUNCT
gra-2158	23	10	dose	dose	NOUN
gra-2158	23	11	combination	combination	NOUN
gra-2158	23	12	therapy	therapy	NOUN
gra-2158	23	13	was	be	AUX
gra-2158	23	14	more	more	ADV
gra-2158	23	15	effective	effective	ADJ
gra-2158	23	16	in	in	ADP
gra-2158	23	17	glycemic	glycemic	ADJ
gra-2158	23	18	control	control	NOUN
gra-2158	23	19	than	than	ADP
gra-2158	23	20	metformin	metformin	NOUN
gra-2158	23	21	uptitration	uptitration	NOUN
gra-2158	23	22	,	,	PUNCT
gra-2158	23	23	and	and	CCONJ
gra-2158	23	24	was	be	AUX
gra-2158	23	25	well	well	ADV
gra-2158	23	26	tolerated	tolerate	VERB
gra-2158	23	27	in	in	ADP
gra-2158	23	28	type	type	NOUN
gra-2158	23	29	2	2	NUM
gra-2158	23	30	diabetic	diabetic	ADJ
gra-2158	23	31	patients	patient	NOUN
gra-2158	23	32	inadequately	inadequately	ADV
gra-2158	23	33	controlled	control	VERB
gra-2158	23	34	by	by	ADP
gra-2158	23	35	low	low	ADJ
gra-2158	23	36	-	-	PUNCT
gra-2158	23	37	dose	dose	VERB
gra-2158	23	38	4metformin	4metformin	PROPN
gra-2158	23	39	monotherapy	monotherapy	NOUN
gra-2158	23	40	in	in	ADP
gra-2158	23	41	korea	korea	PROPN
gra-2158	23	42	.	.	PUNCT
gra-2158	24	1	ortiz	ortiz	PROPN
gra-2158	24	2	et	et	PROPN
gra-2158	24	3	al	al	PROPN
gra-2158	24	4	.	.	PROPN
gra-2158	24	5	,	,	PUNCT
gra-2158	24	6	compare	compare	VERB
gra-2158	24	7	the	the	DET
gra-2158	24	8	efcacy	efcacy	NOUN
gra-2158	24	9	of	of	ADP
gra-2158	24	10	glimepiride	glimepiride	NOUN
gra-2158	24	11	/	/	SYM
gra-2158	24	12	metformin	metformin	NOUN
gra-2158	24	13	combination	combination	NOUN
gra-2158	24	14	versus	versus	ADP
gra-2158	24	15	glibenclamide	glibenclamide	NOUN
gra-2158	24	16	/	/	SYM
gra-2158	24	17	metformin	metformin	NOUN
gra-2158	24	18	for	for	ADP
gra-2158	24	19	reaching	reach	VERB
gra-2158	24	20	glycemic	glycemic	ADJ
gra-2158	24	21	control	control	NOUN
gra-2158	24	22	in	in	ADP
gra-2158	24	23	patients	patient	NOUN
gra-2158	24	24	with	with	ADP
gra-2158	24	25	uncontrolled	uncontrolled	ADJ
gra-2158	24	26	type	type	NOUN
gra-2158	24	27	2	2	NUM
gra-2158	24	28	diabetes	diabetes	NOUN
gra-2158	24	29	mellitus	mellitus	NOUN
gra-2158	24	30	.	.	PUNCT
gra-2158	25	1	a	a	PRON
gra-2158	25	2	randomized	randomized	ADJ
gra-2158	25	3	,	,	PUNCT
gra-2158	25	4	double	double	ADJ
gra-2158	25	5	-	-	PUNCT
gra-2158	25	6	blind	blind	ADJ
gra-2158	25	7	,	,	PUNCT
gra-2158	25	8	multicenter	multicenter	ADJ
gra-2158	25	9	clinical	clinical	ADJ
gra-2158	25	10	trial	trial	NOUN
gra-2158	25	11	was	be	AUX
gra-2158	25	12	performed	perform	VERB
gra-2158	25	13	in	in	ADP
gra-2158	25	14	152	152	NUM
gra-2158	25	15	uncontrolled	uncontrolled	ADJ
gra-2158	25	16	type	type	NOUN
gra-2158	25	17	2	2	NUM
gra-2158	25	18	diabetic	diabetic	ADJ
gra-2158	25	19	patients	patient	NOUN
gra-2158	25	20	.	.	PUNCT
gra-2158	26	1	serum	serum	VERB
gra-2158	26	2	fasting	fasting	NOUN
gra-2158	26	3	and	and	CCONJ
gra-2158	26	4	postprandial	postprandial	ADJ
gra-2158	26	5	glucose	glucose	NOUN
gra-2158	26	6	,	,	PUNCT
gra-2158	26	7	hemoglobin	hemoglobin	NOUN
gra-2158	26	8	a1c	a1c	PROPN
gra-2158	26	9	(	(	PUNCT
gra-2158	26	10	a1c	a1c	PROPN
gra-2158	26	11	)	)	PUNCT
gra-2158	26	12	,	,	PUNCT
gra-2158	26	13	high	high	ADJ
gra-2158	26	14	-	-	PUNCT
gra-2158	26	15	density	density	NOUN
gra-2158	26	16	lipoprotein	lipoprotein	ADJ
gra-2158	26	17	cholesterol	cholesterol	NOUN
gra-2158	26	18	,	,	PUNCT
gra-2158	26	19	and	and	CCONJ
gra-2158	26	20	triglycerides	triglyceride	NOUN
gra-2158	26	21	were	be	AUX
gra-2158	26	22	measured	measure	VERB
gra-2158	26	23	.	.	PUNCT
gra-2158	27	1	each	each	DET
gra-2158	27	2	study	study	NOUN
gra-2158	27	3	group	group	NOUN
gra-2158	27	4	included	include	VERB
gra-2158	27	5	76	76	NUM
gra-2158	27	6	patients	patient	NOUN
gra-2158	27	7	.	.	PUNCT
gra-2158	28	1	no	no	DET
gra-2158	28	2	signicant	signicant	ADJ
gra-2158	28	3	differences	difference	NOUN
gra-2158	28	4	in	in	ADP
gra-2158	28	5	basal	basal	ADJ
gra-2158	28	6	clinical	clinical	ADJ
gra-2158	28	7	and	and	CCONJ
gra-2158	28	8	laboratory	laboratory	NOUN
gra-2158	28	9	characteristics	characteristic	NOUN
gra-2158	28	10	between	between	ADP
gra-2158	28	11	groups	group	NOUN
gra-2158	28	12	were	be	AUX
gra-2158	28	13	found	find	VERB
gra-2158	28	14	.	.	PUNCT
gra-2158	29	1	at	at	ADP
gra-2158	29	2	the	the	DET
gra-2158	29	3	end	end	NOUN
gra-2158	29	4	of	of	ADP
gra-2158	29	5	the	the	DET
gra-2158	29	6	study	study	NOUN
gra-2158	29	7	,	,	PUNCT
gra-2158	29	8	a1c	a1c	PROPN
gra-2158	29	9	concentration	concentration	NOUN
gra-2158	29	10	was	be	AUX
gra-2158	29	11	signicantly	signicantly	ADV
gra-2158	29	12	lower	low	ADJ
gra-2158	29	13	in	in	ADP
gra-2158	29	14	the	the	DET
gra-2158	29	15	glimepiride	glimepiride	NOUN
gra-2158	29	16	/	/	SYM
gra-2158	29	17	metformin	metformin	NOUN
gra-2158	29	18	group	group	NOUN
gra-2158	29	19	(	(	PUNCT
gra-2158	29	20	p=.025	p=.025	PROPN
gra-2158	29	21	)	)	PUNCT
gra-2158	29	22	.	.	PUNCT
gra-2158	30	1	a	a	DET
gra-2158	30	2	higher	high	ADJ
gra-2158	30	3	proportion	proportion	NOUN
gra-2158	30	4	of	of	ADP
gra-2158	30	5	patients	patient	NOUN
gra-2158	30	6	from	from	ADP
gra-2158	30	7	the	the	DET
gra-2158	30	8	glimepiride	glimepiride	NOUN
gra-2158	30	9	group	group	NOUN
gra-2158	30	10	(	(	PUNCT
gra-2158	30	11	44.6	44.6	NUM
gra-2158	30	12	%	%	NOUN
gra-2158	30	13	vs.	vs.	ADP
gra-2158	30	14	26.8	26.8	NUM
gra-2158	30	15	%	%	NOUN
gra-2158	30	16	,	,	PUNCT
gra-2158	30	17	pb.05	pb.05	PROPN
gra-2158	30	18	)	)	PUNCT
gra-2158	30	19	reached	reach	VERB
gra-2158	30	20	the	the	DET
gra-2158	30	21	goal	goal	NOUN
gra-2158	30	22	of	of	ADP
gra-2158	30	23	a1c	a1c	PROPN
gra-2158	30	24	b7	b7	PROPN
gra-2158	30	25	%	%	NOUN
gra-2158	30	26	at	at	ADP
gra-2158	30	27	12	12	NUM
gra-2158	30	28	months	month	NOUN
gra-2158	30	29	of	of	ADP
gra-2158	30	30	treatment	treatment	NOUN
gra-2158	30	31	.	.	PUNCT
gra-2158	31	1	a	a	DET
gra-2158	31	2	higher	high	ADJ
gra-2158	31	3	proportion	proportion	NOUN
gra-2158	31	4	of	of	ADP
gra-2158	31	5	hypoglycemic	hypoglycemic	ADJ
gra-2158	31	6	events	event	NOUN
gra-2158	31	7	were	be	AUX
gra-2158	31	8	observed	observe	VERB
gra-2158	31	9	in	in	ADP
gra-2158	31	10	the	the	DET
gra-2158	31	11	glibenclamide	glibenclamide	ADJ
gra-2158	31	12	group	group	NOUN
gra-2158	31	13	(	(	PUNCT
gra-2158	31	14	28.9	28.9	NUM
gra-2158	31	15	%	%	NOUN
gra-2158	31	16	vs.	vs.	ADP
gra-2158	31	17	17.1	17.1	NUM
gra-2158	31	18	%	%	NOUN
gra-2158	31	19	,	,	PUNCT
gra-2158	31	20	pb.047	pb.047	NOUN
gra-2158	31	21	)	)	PUNCT
gra-2158	31	22	.	.	PUNCT
gra-2158	32	1	it	it	PRON
gra-2158	32	2	was	be	AUX
gra-2158	32	3	found	find	VERB
gra-2158	32	4	that	that	SCONJ
gra-2158	32	5	glimepiride	glimepiride	NOUN
gra-2158	32	6	/	/	SYM
gra-2158	32	7	metformin	metformin	NOUN
gra-2158	32	8	demonstrated	demonstrate	VERB
gra-2158	32	9	being	be	AUX
gra-2158	32	10	more	more	ADV
gra-2158	32	11	efcacious	efcacious	ADJ
gra-2158	32	12	than	than	ADP
gra-2158	32	13	glibenclamide	glibenclamide	NOUN
gra-2158	32	14	/	/	SYM
gra-2158	32	15	metformin	metformin	NOUN
gra-2158	32	16	at	at	ADP
gra-2158	32	17	reaching	reach	VERB
gra-2158	32	18	the	the	DET
gra-2158	32	19	glycemic	glycemic	ADJ
gra-2158	32	20	control	control	NOUN
gra-2158	32	21	goals	goal	NOUN
gra-2158	32	22	with	with	ADP
gra-2158	32	23	less	less	ADJ
gra-2158	32	24	hypoglycemic	hypoglycemic	ADJ
gra-2158	32	25	events	event	NOUN
gra-2158	32	26	in	in	ADP
gra-2158	32	27	5patients	5patient	NOUN
gra-2158	32	28	with	with	ADP
gra-2158	32	29	uncontrolled	uncontrolled	ADJ
gra-2158	32	30	type	type	NOUN
gra-2158	32	31	2	2	NUM
gra-2158	32	32	diabetes	diabetes	NOUN
gra-2158	32	33	mellitus	mellitus	NOUN
gra-2158	32	34	.	.	PUNCT
gra-2158	33	1	young	young	ADJ
gra-2158	33	2	park	park	NOUN
gra-2158	33	3	et	et	PROPN
gra-2158	33	4	al	al	PROPN
gra-2158	33	5	.	.	PROPN
gra-2158	33	6	,	,	PUNCT
gra-2158	33	7	compare	compare	VERB
gra-2158	33	8	the	the	DET
gra-2158	33	9	commonly	commonly	ADV
gra-2158	33	10	prescribed	prescribe	VERB
gra-2158	33	11	oral	oral	ADJ
gra-2158	33	12	antidiabetic	antidiabetic	ADJ
gra-2158	33	13	drug	drug	NOUN
gra-2158	33	14	(	(	PUNCT
gra-2158	33	15	oad	oad	NOUN
gra-2158	33	16	)	)	PUNCT
gra-2158	33	17	combinations	combination	NOUN
gra-2158	33	18	to	to	PART
gra-2158	33	19	use	use	VERB
gra-2158	33	20	as	as	ADP
gra-2158	33	21	add	add	VERB
gra-2158	33	22	-	-	PUNCT
gra-2158	33	23	on	on	ADP
gra-2158	33	24	therapy	therapy	NOUN
gra-2158	33	25	with	with	ADP
gra-2158	33	26	insulin	insulin	NOUN
gra-2158	33	27	glargine	glargine	NOUN
gra-2158	33	28	in	in	ADP
gra-2158	33	29	patients	patient	NOUN
gra-2158	33	30	with	with	ADP
gra-2158	33	31	uncontrolled	uncontrolled	ADJ
gra-2158	33	32	type	type	NOUN
gra-2158	33	33	2	2	NUM
gra-2158	33	34	addition	addition	NOUN
gra-2158	33	35	of	of	ADP
gra-2158	33	36	voglibose	voglibose	NOUN
gra-2158	33	37	to	to	ADP
gra-2158	33	38	the	the	DET
gra-2158	33	39	dual	dual	ADJ
gra-2158	33	40	combination	combination	NOUN
gra-2158	33	41	therapy	therapy	NOUN
gra-2158	33	42	of	of	ADP
gra-2158	33	43	glimepiride	glimepiride	NOUN
gra-2158	33	44	and	and	CCONJ
gra-2158	33	45	metformin	metformin	NOUN
gra-2158	33	46	in	in	ADP
gra-2158	33	47	the	the	DET
gra-2158	33	48	management	management	NOUN
gra-2158	33	49	of	of	ADP
gra-2158	33	50	type	type	NOUN
gra-2158	33	51	2	2	NUM
gra-2158	33	52	diabetes	diabetes	NOUN
gra-2158	33	53	original	original	ADJ
gra-2158	33	54	research	research	NOUN
gra-2158	33	55	paper	paper	NOUN
gra-2158	33	56	x	x	X
gra-2158	33	57	41gjra	41gjra	PROPN
gra-2158	33	58	global	global	ADJ
gra-2158	33	59	journal	journal	PROPN
gra-2158	33	60	for	for	ADP
gra-2158	33	61	research	research	NOUN
gra-2158	33	62	analysis	analysis	NOUN
gra-2158	33	63	medicine	medicine	NOUN
gra-2158	33	64	volume-9	volume-9	NOUN
gra-2158	33	65	,	,	PUNCT
gra-2158	33	66	issue-3	issue-3	NUM
gra-2158	33	67	,	,	PUNCT
gra-2158	33	68	march-2020	march-2020	ADJ
gra-2158	33	69	•	•	NOUN
gra-2158	33	70	print	print	NOUN
gra-2158	33	71	issn	issn	PROPN
gra-2158	33	72	no	no	NOUN
gra-2158	33	73	.	.	PROPN
gra-2158	33	74	2277	2277	NUM
gra-2158	33	75	8160	8160	NUM
gra-2158	33	76	•	•	NOUN
gra-2158	33	77	doi	doi	NOUN
gra-2158	33	78	:	:	PUNCT
gra-2158	33	79	10.36106	10.36106	NUM
gra-2158	33	80	/	/	SYM
gra-2158	33	81	gjra	gjra	PROPN
gra-2158	33	82	dr	dr	PROPN
gra-2158	33	83	bharat	bharat	PROPN
gra-2158	33	84	gupta	gupta	PROPN
gra-2158	33	85	kalyan	kalyan	PROPN
gra-2158	33	86	health	health	PROPN
gra-2158	33	87	care	care	PROPN
gra-2158	33	88	,	,	PUNCT
gra-2158	33	89	m.	m.	PROPN
gra-2158	33	90	r.	r.	PROPN
gra-2158	33	91	complex	complex	PROPN
gra-2158	33	92	,	,	PUNCT
gra-2158	33	93	near	near	ADP
gra-2158	33	94	bhuteshwar	bhuteshwar	NOUN
gra-2158	33	95	temple	temple	NOUN
gra-2158	33	96	,	,	PUNCT
gra-2158	33	97	bhuteshwar	bhuteshwar	PROPN
gra-2158	33	98	,	,	PUNCT
gra-2158	33	99	mathura	mathura	NOUN
gra-2158	33	100	281004	281004	NUM
gra-2158	33	101	keywords	keyword	NOUN
gra-2158	33	102	:	:	PUNCT
gra-2158	33	103	dr	dr	PROPN
gra-2158	33	104	girish	girish	PROPN
gra-2158	33	105	hiregaudar	hiregaudar	PROPN
gra-2158	33	106	*	*	PROPN
gra-2158	33	107	vallabh	vallabh	PROPN
gra-2158	33	108	clinic	clinic	NOUN
gra-2158	33	109	,	,	PUNCT
gra-2158	33	110	ruikar	ruikar	NOUN
gra-2158	33	111	colony	colony	NOUN
gra-2158	33	112	,	,	PUNCT
gra-2158	33	113	kolhapur,416005	kolhapur,416005	PROPN
gra-2158	33	114	*	*	PUNCT
gra-2158	33	115	corresponding	correspond	VERB
gra-2158	33	116	author	author	NOUN
gra-2158	33	117	dr	dr	PROPN
gra-2158	33	118	lakshman	lakshman	PROPN
gra-2158	33	119	jambgi	jambgi	PROPN
gra-2158	33	120	ashirwad	ashirwad	PROPN
gra-2158	33	121	hospital	hospital	PROPN
gra-2158	33	122	head	head	NOUN
gra-2158	33	123	post	post	VERB
gra-2158	33	124	harugeri	harugeri	PROPN
gra-2158	33	125	-591220	-591220	PROPN
gra-2158	33	126	dr	dr	PROPN
gra-2158	33	127	kiran	kiran	PROPN
gra-2158	33	128	patil	patil	PROPN
gra-2158	33	129	501/502	501/502	PROPN
gra-2158	33	130	vishal	vishal	PROPN
gra-2158	33	131	villa	villa	PROPN
gra-2158	33	132	,	,	PUNCT
gra-2158	33	133	plot	plot	NOUN
gra-2158	33	134	no	no	INTJ
gra-2158	33	135	.	.	NOUN
gra-2158	33	136	167	167	NUM
gra-2158	33	137	,	,	PUNCT
gra-2158	33	138	veer	veer	NOUN
gra-2158	33	139	savarkar	savarkar	NOUN
gra-2158	33	140	marg	marg	PROPN
gra-2158	33	141	,	,	PUNCT
gra-2158	33	142	shivaji	shivaji	PROPN
gra-2158	33	143	park	park	PROPN
gra-2158	33	144	dadar	dadar	PROPN
gra-2158	33	145	west	west	PROPN
gra-2158	33	146	,	,	PUNCT
gra-2158	33	147	mumbai-400028	mumbai-400028	PROPN
gra-2158	33	148	dr	dr	PROPN
gra-2158	33	149	mahesh	mahesh	PROPN
gra-2158	33	150	p	p	PROPN
gra-2158	33	151	rdshiva	rdshiva	PROPN
gra-2158	33	152	speciality	speciality	PROPN
gra-2158	33	153	clinic	clinic	NOUN
gra-2158	33	154	,	,	PUNCT
gra-2158	33	155	#	#	SYM
gra-2158	33	156	212	212	NUM
gra-2158	33	157	,	,	PUNCT
gra-2158	33	158	ground	ground	NOUN
gra-2158	33	159	floor	floor	NOUN
gra-2158	33	160	,	,	PUNCT
gra-2158	33	161	4th	4th	ADJ
gra-2158	33	162	cross	cross	NOUN
gra-2158	33	163	,	,	PUNCT
gra-2158	33	164	3	3	NUM
gra-2158	33	165	main	main	ADJ
gra-2158	33	166	,	,	PUNCT
gra-2158	33	167	dr	dr	PROPN
gra-2158	33	168	shivaramkaranth	shivaramkaranth	PROPN
gra-2158	33	169	road	road	NOUN
gra-2158	33	170	,	,	PUNCT
gra-2158	33	171	hanumanthnagar	hanumanthnagar	NOUN
gra-2158	33	172	bangalore-560019	bangalore-560019	VERB
gra-2158	33	173	42	42	NUM
gra-2158	33	174	x	x	SYM
gra-2158	33	175	gjra	gjra	ADJ
gra-2158	33	176	global	global	ADJ
gra-2158	33	177	journal	journal	PROPN
gra-2158	33	178	for	for	ADP
gra-2158	33	179	research	research	NOUN
gra-2158	33	180	analysis	analysis	NOUN
gra-2158	33	181	diabetes	diabetes	NOUN
gra-2158	33	182	despite	despite	SCONJ
gra-2158	33	183	submaximal	submaximal	ADJ
gra-2158	33	184	doses	dose	NOUN
gra-2158	33	185	of	of	ADP
gra-2158	33	186	oads	oad	NOUN
gra-2158	33	187	.	.	PUNCT
gra-2158	34	1	99	99	NUM
gra-2158	34	2	patients	patient	NOUN
gra-2158	34	3	with	with	ADP
gra-2158	34	4	inadequately	inadequately	ADV
gra-2158	34	5	controlled	control	VERB
gra-2158	34	6	type	type	NOUN
gra-2158	34	7	2	2	NUM
gra-2158	34	8	diabetes	diabetes	NOUN
gra-2158	34	9	were	be	AUX
gra-2158	34	10	randomly	randomly	ADV
gra-2158	34	11	assigned	assign	VERB
gra-2158	34	12	on	on	ADP
gra-2158	34	13	a	a	DET
gra-2158	34	14	1:1:1	1:1:1	PROPN
gra-2158	34	15	basis	basis	NOUN
gra-2158	34	16	to	to	PART
gra-2158	34	17	receive	receive	VERB
gra-2158	34	18	insulin	insulin	NOUN
gra-2158	34	19	glargine	glargine	NOUN
gra-2158	34	20	,	,	PUNCT
gra-2158	34	21	with	with	ADP
gra-2158	34	22	xed	xe	VERB
gra-2158	34	23	doses	dose	NOUN
gra-2158	34	24	of	of	ADP
gra-2158	34	25	glimepiride	glimepiride	NOUN
gra-2158	34	26	,	,	PUNCT
gra-2158	34	27	metformin	metformin	NOUN
gra-2158	34	28	,	,	PUNCT
gra-2158	34	29	and	and	CCONJ
gra-2158	34	30	glimepiride	glimepiride	NOUN
gra-2158	34	31	plus	plus	CCONJ
gra-2158	34	32	metformin	metformin	NOUN
gra-2158	34	33	.	.	PUNCT
gra-2158	35	1	outcomes	outcome	NOUN
gra-2158	35	2	assessed	assess	VERB
gra-2158	35	3	included	include	VERB
gra-2158	35	4	hba1c	hba1c	PROPN
gra-2158	35	5	,	,	PUNCT
gra-2158	35	6	the	the	DET
gra-2158	35	7	changes	change	NOUN
gra-2158	35	8	in	in	ADP
gra-2158	35	9	fasting	fast	VERB
gra-2158	35	10	glucose	glucose	NOUN
gra-2158	35	11	levels	level	NOUN
gra-2158	35	12	,	,	PUNCT
gra-2158	35	13	body	body	NOUN
gra-2158	35	14	weight	weight	NOUN
gra-2158	35	15	,	,	PUNCT
gra-2158	35	16	serum	serum	NOUN
gra-2158	35	17	lipids	lipids	ADJ
gra-2158	35	18	values	value	NOUN
gra-2158	35	19	,	,	PUNCT
gra-2158	35	20	insulin	insulin	NOUN
gra-2158	35	21	dose	dose	NOUN
gra-2158	35	22	,	,	PUNCT
gra-2158	35	23	and	and	CCONJ
gra-2158	35	24	symptomatic	symptomatic	ADJ
gra-2158	35	25	hypoglycemia	hypoglycemia	NOUN
gra-2158	35	26	.	.	PUNCT
gra-2158	36	1	after	after	ADP
gra-2158	36	2	24	24	NUM
gra-2158	36	3	weeks	week	NOUN
gra-2158	36	4	,	,	PUNCT
gra-2158	36	5	hba1c	hba1c	PROPN
gra-2158	36	6	levels	level	NOUN
gra-2158	36	7	improved	improve	VERB
gra-2158	36	8	from	from	ADP
gra-2158	36	9	(	(	PUNCT
gra-2158	36	10	mean	mean	PROPN
gra-2158	36	11	±	±	NUM
gra-2158	36	12	sd	sd	NOUN
gra-2158	36	13	)	)	PUNCT
gra-2158	36	14	8.5±0.9	8.5±0.9	NUM
gra-2158	36	15	%	%	NOUN
gra-2158	36	16	to	to	PART
gra-2158	36	17	7.7±0.8	7.7±0.8	NUM
gra-2158	36	18	%	%	NOUN
gra-2158	36	19	(	(	PUNCT
gra-2158	36	20	69.0±10.0	69.0±10.0	NUM
gra-2158	36	21	mmol	mmol	NOUN
gra-2158	36	22	/	/	SYM
gra-2158	36	23	mol	mol	NOUN
gra-2158	36	24	to	to	ADP
gra-2158	36	25	60.8±8.6	60.8±8.6	NUM
gra-2158	36	26	mmol	mmol	NOUN
gra-2158	36	27	/	/	SYM
gra-2158	36	28	mol	mol	NOUN
gra-2158	36	29	)	)	PUNCT
gra-2158	36	30	with	with	ADP
gra-2158	36	31	insulin	insulin	NOUN
gra-2158	36	32	glargine	glargine	NOUN
gra-2158	36	33	plus	plus	CCONJ
gra-2158	36	34	metformin	metformin	NOUN
gra-2158	36	35	,	,	PUNCT
gra-2158	36	36	from	from	ADP
gra-2158	36	37	8.4±1.0	8.4±1.0	NUM
gra-2158	36	38	%	%	NOUN
gra-2158	36	39	to	to	PART
gra-2158	36	40	7.7±1.3	7.7±1.3	NUM
gra-2158	36	41	%	%	NOUN
gra-2158	36	42	(	(	PUNCT
gra-2158	36	43	68.8±10.6	68.8±10.6	NUM
gra-2158	36	44	mmol	mmol	NOUN
gra-2158	36	45	/	/	SYM
gra-2158	36	46	mol	mol	NOUN
gra-2158	36	47	to	to	ADP
gra-2158	36	48	61.1±14.4	61.1±14.4	NUM
gra-2158	36	49	mmol	mmol	NOUN
gra-2158	36	50	/	/	SYM
gra-2158	36	51	mol	mol	NOUN
gra-2158	36	52	)	)	PUNCT
gra-2158	36	53	with	with	ADP
gra-2158	36	54	insulin	insulin	NOUN
gra-2158	36	55	glargine	glargine	NOUN
gra-2158	36	56	plus	plus	CCONJ
gra-2158	36	57	glimepiride	glimepiride	NOUN
gra-2158	36	58	and	and	CCONJ
gra-2158	36	59	from	from	ADP
gra-2158	36	60	8.7±0.9	8.7±0.9	NUM
gra-2158	36	61	%	%	NOUN
gra-2158	36	62	to	to	PART
gra-2158	36	63	7.3±0.6	7.3±0.6	NUM
gra-2158	36	64	%	%	NOUN
gra-2158	36	65	(	(	PUNCT
gra-2158	36	66	71.7±9.8	71.7±9.8	NUM
gra-2158	36	67	mmol	mmol	NOUN
gra-2158	36	68	/	/	SYM
gra-2158	36	69	mol	mol	ADP
gra-2158	36	70	to	to	ADP
gra-2158	36	71	56.2±6.7	56.2±6.7	NUM
gra-2158	36	72	mmol	mmol	NOUN
gra-2158	36	73	/	/	SYM
gra-2158	36	74	mol	mol	NOUN
gra-2158	36	75	)	)	PUNCT
gra-2158	36	76	with	with	ADP
gra-2158	36	77	insulin	insulin	NOUN
gra-2158	36	78	glargine	glargine	NOUN
gra-2158	36	79	plus	plus	CCONJ
gra-2158	36	80	glimepiride	glimepiride	NOUN
gra-2158	36	81	plus	plus	CCONJ
gra-2158	36	82	metformin	metformin	NOUN
gra-2158	36	83	.	.	PUNCT
gra-2158	37	1	the	the	DET
gra-2158	37	2	decrease	decrease	NOUN
gra-2158	37	3	in	in	ADP
gra-2158	37	4	hba1c	hba1c	PROPN
gra-2158	37	5	was	be	AUX
gra-2158	37	6	more	more	ADV
gra-2158	37	7	pronounced	pronounced	ADJ
gra-2158	37	8	with	with	ADP
gra-2158	37	9	insulin	insulin	NOUN
gra-2158	37	10	glargine	glargine	NOUN
gra-2158	37	11	plus	plus	CCONJ
gra-2158	37	12	glimepiride	glimepiride	NOUN
gra-2158	37	13	plus	plus	CCONJ
gra-2158	37	14	metformin	metformin	NOUN
gra-2158	37	15	than	than	ADP
gra-2158	37	16	with	with	ADP
gra-2158	37	17	insulin	insulin	NOUN
gra-2158	37	18	glargine	glargine	NOUN
gra-2158	37	19	plus	plus	CCONJ
gra-2158	37	20	metformin	metformin	NOUN
gra-2158	37	21	(	(	PUNCT
gra-2158	37	22	0.49	0.49	NUM
gra-2158	37	23	%	%	NOUN
gra-2158	37	24	[	[	X
gra-2158	37	25	ci	ci	NOUN
gra-2158	37	26	,	,	PUNCT
gra-2158	37	27	0.16	0.16	NUM
gra-2158	37	28	%	%	NOUN
gra-2158	37	29	to	to	PART
gra-2158	37	30	0.82	0.82	NUM
gra-2158	37	31	%	%	NOUN
gra-2158	37	32	]	]	X
gra-2158	37	33	;	;	PUNCT
gra-2158	37	34	p	p	X
gra-2158	37	35	=	=	NOUN
gra-2158	37	36	0.005	0.005	NUM
gra-2158	37	37	)	)	PUNCT
gra-2158	37	38	(	(	PUNCT
gra-2158	37	39	5.10	5.10	NUM
gra-2158	37	40	mmol	mmol	NOUN
gra-2158	37	41	/	/	SYM
gra-2158	37	42	mol	mol	ADP
gra-2158	37	43	[	[	X
gra-2158	37	44	ci	ci	NOUN
gra-2158	37	45	,	,	PUNCT
gra-2158	37	46	1.64	1.64	NUM
gra-2158	37	47	to	to	ADP
gra-2158	37	48	8.61	8.61	NUM
gra-2158	37	49	]	]	PUNCT
gra-2158	37	50	;	;	PUNCT
gra-2158	37	51	p	p	X
gra-2158	37	52	=	=	NOUN
gra-2158	37	53	0.005	0.005	NUM
gra-2158	37	54	)	)	PUNCT
gra-2158	37	55	and	and	CCONJ
gra-2158	37	56	insulin	insulin	NOUN
gra-2158	37	57	glargine	glargine	NOUN
gra-2158	37	58	plus	plus	CCONJ
gra-2158	37	59	glimepiride	glimepiride	NOUN
gra-2158	37	60	(	(	PUNCT
gra-2158	37	61	0.59	0.59	NUM
gra-2158	37	62	%	%	NOUN
gra-2158	37	63	[	[	X
gra-2158	37	64	ci	ci	NOUN
gra-2158	37	65	,	,	PUNCT
gra-2158	37	66	0.13	0.13	NUM
gra-2158	37	67	%	%	NOUN
gra-2158	37	68	to	to	PART
gra-2158	37	69	1.05	1.05	NUM
gra-2158	37	70	%	%	NOUN
gra-2158	37	71	]	]	X
gra-2158	37	72	;	;	PUNCT
gra-2158	37	73	p	p	X
gra-2158	37	74	=	=	PROPN
gra-2158	37	75	0.012	0.012	NUM
gra-2158	37	76	)	)	PUNCT
gra-2158	37	77	(	(	PUNCT
gra-2158	37	78	5.87	5.87	NUM
gra-2158	37	79	mmol	mmol	NOUN
gra-2158	37	80	/	/	SYM
gra-2158	37	81	mol	mol	ADP
gra-2158	37	82	[	[	X
gra-2158	37	83	ci	ci	NOUN
gra-2158	37	84	,	,	PUNCT
gra-2158	37	85	1.10	1.10	NUM
gra-2158	37	86	to	to	ADP
gra-2158	37	87	10.64	10.64	NUM
gra-2158	37	88	]	]	PUNCT
gra-2158	37	89	;	;	PUNCT
gra-2158	37	90	p	p	X
gra-2158	37	91	=	=	PROPN
gra-2158	37	92	0.012	0.012	NUM
gra-2158	37	93	)	)	PUNCT
gra-2158	37	94	(	(	PUNCT
gra-2158	37	95	overall	overall	ADV
gra-2158	37	96	p	p	X
gra-2158	37	97	=	=	NOUN
gra-2158	37	98	0.02	0.02	NUM
gra-2158	37	99	)	)	PUNCT
gra-2158	37	100	.	.	PUNCT
gra-2158	38	1	weight	weight	NOUN
gra-2158	38	2	gain	gain	NOUN
gra-2158	38	3	and	and	CCONJ
gra-2158	38	4	the	the	DET
gra-2158	38	5	risk	risk	NOUN
gra-2158	38	6	of	of	ADP
gra-2158	38	7	hypoglycemia	hypoglycemia	NOUN
gra-2158	38	8	of	of	ADP
gra-2158	38	9	any	any	DET
gra-2158	38	10	type	type	NOUN
gra-2158	38	11	did	do	AUX
gra-2158	38	12	not	not	PART
gra-2158	38	13	signicantly	signicantly	ADV
gra-2158	38	14	differ	differ	VERB
gra-2158	38	15	among	among	ADP
gra-2158	38	16	the	the	DET
gra-2158	38	17	treatment	treatment	NOUN
gra-2158	38	18	groups	group	NOUN
gra-2158	38	19	.	.	PUNCT
gra-2158	39	1	it	it	PRON
gra-2158	39	2	was	be	AUX
gra-2158	39	3	concluded	conclude	VERB
gra-2158	39	4	that	that	SCONJ
gra-2158	39	5	the	the	DET
gra-2158	39	6	combination	combination	NOUN
gra-2158	39	7	therapy	therapy	NOUN
gra-2158	39	8	of	of	ADP
gra-2158	39	9	metformin	metformin	NOUN
gra-2158	39	10	and	and	CCONJ
gra-2158	39	11	glimepiride	glimepiride	NOUN
gra-2158	39	12	plus	plus	CCONJ
gra-2158	39	13	glargine	glargine	NOUN
gra-2158	39	14	insulin	insulin	NOUN
gra-2158	39	15	resulted	result	VERB
gra-2158	39	16	in	in	ADP
gra-2158	39	17	a	a	DET
gra-2158	39	18	signicant	signicant	ADJ
gra-2158	39	19	improvement	improvement	NOUN
gra-2158	39	20	in	in	ADP
gra-2158	39	21	overall	overall	ADJ
gra-2158	39	22	glycemic	glycemic	ADJ
gra-2158	39	23	control	control	NOUN
gra-2158	39	24	as	as	SCONJ
gra-2158	39	25	compared	compare	VERB
gra-2158	39	26	with	with	ADP
gra-2158	39	27	the	the	DET
gra-2158	39	28	6other	6other	PROPN
gra-2158	39	29	combinations	combination	NOUN
gra-2158	39	30	.	.	PUNCT
gra-2158	40	1	although	although	SCONJ
gra-2158	40	2	the	the	DET
gra-2158	40	3	combination	combination	NOUN
gra-2158	40	4	of	of	ADP
gra-2158	40	5	a	a	DET
gra-2158	40	6	sulfonylurea	sulfonylurea	NOUN
gra-2158	40	7	with	with	ADP
gra-2158	40	8	metformin	metformin	NOUN
gra-2158	40	9	is	be	AUX
gra-2158	40	10	commonly	commonly	ADV
gra-2158	40	11	used	use	VERB
gra-2158	40	12	in	in	ADP
gra-2158	40	13	clinical	clinical	ADJ
gra-2158	40	14	practice	practice	NOUN
gra-2158	40	15	,	,	PUNCT
gra-2158	40	16	however	however	ADV
gra-2158	40	17	,	,	PUNCT
gra-2158	40	18	when	when	SCONJ
gra-2158	40	19	this	this	DET
gra-2158	40	20	potent	potent	ADJ
gra-2158	40	21	combination	combination	NOUN
gra-2158	40	22	is	be	AUX
gra-2158	40	23	no	no	ADV
gra-2158	40	24	longer	long	ADV
gra-2158	40	25	able	able	ADJ
gra-2158	40	26	to	to	PART
gra-2158	40	27	provide	provide	VERB
gra-2158	40	28	acceptable	acceptable	ADJ
gra-2158	40	29	glycemic	glycemic	ADJ
gra-2158	40	30	control	control	NOUN
gra-2158	40	31	,	,	PUNCT
gra-2158	40	32	the	the	DET
gra-2158	40	33	addition	addition	NOUN
gra-2158	40	34	of	of	ADP
gra-2158	40	35	an	an	DET
gra-2158	40	36	antidiabetic	antidiabetic	ADJ
gra-2158	40	37	drug	drug	NOUN
gra-2158	40	38	with	with	ADP
gra-2158	40	39	a	a	DET
gra-2158	40	40	different	different	ADJ
gra-2158	40	41	1mode	1mode	NUM
gra-2158	40	42	of	of	ADP
gra-2158	40	43	action	action	NOUN
gra-2158	40	44	may	may	AUX
gra-2158	40	45	lead	lead	VERB
gra-2158	40	46	to	to	ADP
gra-2158	40	47	improved	improve	VERB
gra-2158	40	48	metabolic	metabolic	NOUN
gra-2158	40	49	control	control	NOUN
gra-2158	40	50	.	.	PUNCT
gra-2158	41	1	the	the	DET
gra-2158	41	2	addition	addition	NOUN
gra-2158	41	3	of	of	ADP
gra-2158	41	4	the	the	DET
gra-2158	41	5	second	second	ADJ
gra-2158	41	6	agent	agent	NOUN
gra-2158	41	7	usually	usually	ADV
gra-2158	41	8	lowers	lower	VERB
gra-2158	41	9	the	the	DET
gra-2158	41	10	mean	mean	ADJ
gra-2158	41	11	hba1c	hba1c	ADJ
gra-2158	41	12	level	level	NOUN
gra-2158	41	13	of	of	ADP
gra-2158	41	14	1.0	1.0	NUM
gra-2158	41	15	to	to	PART
gra-2158	41	16	1.4	1.4	NUM
gra-2158	41	17	%	%	NOUN
gra-2158	41	18	more	more	ADJ
gra-2158	41	19	than	than	ADP
gra-2158	41	20	monotherapy	monotherapy	NOUN
gra-2158	41	21	when	when	SCONJ
gra-2158	41	22	the	the	DET
gra-2158	41	23	baseline	baseline	NOUN
gra-2158	41	24	value	value	NOUN
gra-2158	41	25	is	be	AUX
gra-2158	41	26	between	between	ADP
gra-2158	41	27	8.5	8.5	NUM
gra-2158	41	28	%	%	NOUN
gra-2158	41	29	and	and	CCONJ
gra-2158	41	30	9.5	9.5	NUM
gra-2158	41	31	%	%	NOUN
gra-2158	41	32	.	.	PUNCT
gra-2158	42	1	thus	thus	ADV
gra-2158	42	2	by	by	ADP
gra-2158	42	3	using	use	VERB
gra-2158	42	4	dual	dual	ADJ
gra-2158	42	5	therapy	therapy	NOUN
gra-2158	42	6	and	and	CCONJ
gra-2158	42	7	when	when	SCONJ
gra-2158	42	8	the	the	DET
gra-2158	42	9	hba1c	hba1c	PROPN
gra-2158	42	10	is	be	AUX
gra-2158	42	11	>	>	X
gra-2158	42	12	9	9	NUM
gra-2158	42	13	it	it	PRON
gra-2158	42	14	is	be	AUX
gra-2158	42	15	not	not	PART
gra-2158	42	16	possible	possible	ADJ
gra-2158	42	17	to	to	PART
gra-2158	42	18	achieve	achieve	VERB
gra-2158	42	19	the	the	DET
gra-2158	42	20	desired	desire	VERB
gra-2158	42	21	hba1c	hba1c	PROPN
gra-2158	42	22	target	target	NOUN
gra-2158	42	23	i.e.	i.e.	X
gra-2158	42	24	<	<	X
gra-2158	42	25	6.5	6.5	NUM
gra-2158	42	26	%	%	NOUN
gra-2158	42	27	.	.	PUNCT
gra-2158	43	1	thus	thus	ADV
gra-2158	43	2	,	,	PUNCT
gra-2158	43	3	it	it	PRON
gra-2158	43	4	is	be	AUX
gra-2158	43	5	proposed	propose	VERB
gra-2158	43	6	that	that	SCONJ
gra-2158	43	7	a	a	DET
gra-2158	43	8	third	third	ADJ
gra-2158	43	9	agent	agent	NOUN
gra-2158	43	10	with	with	ADP
gra-2158	43	11	a	a	DET
gra-2158	43	12	different	different	ADJ
gra-2158	43	13	mechanism	mechanism	NOUN
gra-2158	43	14	of	of	ADP
gra-2158	43	15	action	action	NOUN
gra-2158	43	16	can	can	AUX
gra-2158	43	17	be	be	AUX
gra-2158	43	18	added	add	VERB
gra-2158	43	19	to	to	ADP
gra-2158	43	20	the	the	DET
gra-2158	43	21	existing	exist	VERB
gra-2158	43	22	dual	dual	ADJ
gra-2158	43	23	therapy	therapy	NOUN
gra-2158	43	24	if	if	SCONJ
gra-2158	43	25	the	the	DET
gra-2158	43	26	hba1c	hba1c	PROPN
gra-2158	43	27	level	level	NOUN
gra-2158	43	28	achieved	achieve	VERB
gra-2158	43	29	with	with	ADP
gra-2158	43	30	two	two	NUM
gra-2158	43	31	agents	agent	NOUN
gra-2158	43	32	is	be	AUX
gra-2158	43	33	8.0	8.0	NUM
gra-2158	43	34	%	%	NOUN
gra-2158	43	35	or	or	CCONJ
gra-2158	43	36	less	less	ADJ
gra-2158	43	37	.	.	PUNCT
gra-2158	44	1	it	it	PRON
gra-2158	44	2	has	have	AUX
gra-2158	44	3	been	be	AUX
gra-2158	44	4	observed	observe	VERB
gra-2158	44	5	that	that	SCONJ
gra-2158	44	6	postprandial	postprandial	ADJ
gra-2158	44	7	glucose	glucose	NOUN
gra-2158	44	8	level	level	NOUN
gra-2158	44	9	plays	play	VERB
gra-2158	44	10	a	a	DET
gra-2158	44	11	major	major	ADJ
gra-2158	44	12	role	role	NOUN
gra-2158	44	13	in	in	ADP
gra-2158	44	14	complications	complication	NOUN
gra-2158	44	15	,	,	PUNCT
gra-2158	44	16	thus	thus	ADV
gra-2158	44	17	besides	besides	SCONJ
gra-2158	44	18	controlling	control	VERB
gra-2158	44	19	the	the	DET
gra-2158	44	20	fasting	fasting	NOUN
gra-2158	44	21	glucose	glucose	NOUN
gra-2158	44	22	,	,	PUNCT
gra-2158	44	23	it	it	PRON
gra-2158	44	24	is	be	AUX
gra-2158	44	25	very	very	ADV
gra-2158	44	26	important	important	ADJ
gra-2158	44	27	to	to	PART
gra-2158	44	28	control	control	VERB
gra-2158	44	29	the	the	DET
gra-2158	44	30	postprandial	postprandial	ADJ
gra-2158	44	31	glucose	glucose	NOUN
gra-2158	44	32	level	level	NOUN
gra-2158	44	33	aggressively	aggressively	ADV
gra-2158	44	34	.	.	PUNCT
gra-2158	45	1	thus	thus	ADV
gra-2158	45	2	a	a	DET
gra-2158	45	3	triple	triple	ADJ
gra-2158	45	4	-	-	PUNCT
gra-2158	45	5	drug	drug	NOUN
gra-2158	45	6	combination	combination	NOUN
gra-2158	45	7	is	be	AUX
gra-2158	45	8	suggested	suggest	VERB
gra-2158	45	9	that	that	SCONJ
gra-2158	45	10	can	can	AUX
gra-2158	45	11	specically	specically	ADV
gra-2158	45	12	control	control	VERB
gra-2158	45	13	postprandial	postprandial	ADJ
gra-2158	45	14	hyperglycemia	hyperglycemia	NOUN
gra-2158	45	15	by	by	ADP
gra-2158	45	16	7reducing	7reduce	VERB
gra-2158	45	17	intestinal	intestinal	ADJ
gra-2158	45	18	glucose	glucose	NOUN
gra-2158	45	19	absorption	absorption	NOUN
gra-2158	45	20	.	.	PUNCT
gra-2158	46	1	a	a	DET
gra-2158	46	2	combination	combination	NOUN
gra-2158	46	3	of	of	ADP
gra-2158	46	4	voglibose	voglibose	NOUN
gra-2158	46	5	,	,	PUNCT
gra-2158	46	6	metformin	metformin	NOUN
gra-2158	46	7	and	and	CCONJ
gra-2158	46	8	glimepiride	glimepiride	NOUN
gra-2158	46	9	is	be	AUX
gra-2158	46	10	one	one	NUM
gra-2158	46	11	such	such	ADJ
gra-2158	46	12	combination	combination	NOUN
gra-2158	46	13	.	.	PUNCT
gra-2158	47	1	all	all	DET
gra-2158	47	2	three	three	NUM
gra-2158	47	3	drugs	drug	NOUN
gra-2158	47	4	act	act	VERB
gra-2158	47	5	by	by	ADP
gra-2158	47	6	different	different	ADJ
gra-2158	47	7	mechanisms	mechanism	NOUN
gra-2158	47	8	and	and	CCONJ
gra-2158	47	9	can	can	AUX
gra-2158	47	10	control	control	VERB
gra-2158	47	11	both	both	PRON
gra-2158	47	12	fasting	fast	VERB
gra-2158	47	13	and	and	CCONJ
gra-2158	47	14	postprandial	postprandial	ADJ
gra-2158	47	15	glucose	glucose	NOUN
gra-2158	47	16	levels	level	NOUN
gra-2158	47	17	.	.	PUNCT
gra-2158	48	1	voglibose	voglibose	NOUN
gra-2158	48	2	is	be	AUX
gra-2158	48	3	an	an	DET
gra-2158	48	4	alpha	alpha	NOUN
gra-2158	48	5	-	-	PUNCT
gra-2158	48	6	glucosidase	glucosidase	ADJ
gra-2158	48	7	inhibitor	inhibitor	NOUN
gra-2158	48	8	,	,	PUNCT
gra-2158	48	9	known	know	VERB
gra-2158	48	10	for	for	ADP
gra-2158	48	11	its	its	PRON
gra-2158	48	12	ability	ability	NOUN
gra-2158	48	13	to	to	PART
gra-2158	48	14	increase	increase	VERB
gra-2158	48	15	and	and	CCONJ
gra-2158	48	16	prolong	prolong	VERB
gra-2158	48	17	glucagon	glucagon	NOUN
gra-2158	48	18	-	-	PUNCT
gra-2158	48	19	like	like	ADJ
gra-2158	48	20	peptide-1	peptide-1	PROPN
gra-2158	48	21	(	(	PUNCT
gra-2158	48	22	glp1	glp1	NOUN
gra-2158	48	23	)	)	PUNCT
gra-2158	48	24	secretion	secretion	NOUN
gra-2158	48	25	in	in	ADP
gra-2158	48	26	t2	t2	NOUN
gra-2158	48	27	dm	dm	NUM
gra-2158	48	28	subjects	subject	NOUN
gra-2158	48	29	which	which	PRON
gra-2158	48	30	shows	show	VERB
gra-2158	48	31	inhibitory	inhibitory	ADJ
gra-2158	48	32	action	action	NOUN
gra-2158	48	33	on	on	ADP
gra-2158	48	34	glucagon	glucagon	NOUN
gra-2158	48	35	secretion	secretion	NOUN
gra-2158	48	36	and	and	CCONJ
gra-2158	48	37	lowers	lower	VERB
gra-2158	48	38	fasting	fast	VERB
gra-2158	48	39	glucose	glucose	NOUN
gra-2158	48	40	levels	level	NOUN
gra-2158	48	41	.	.	PUNCT
gra-2158	49	1	increased	increase	VERB
gra-2158	49	2	release	release	NOUN
gra-2158	49	3	of	of	ADP
gra-2158	49	4	glp-1	glp-1	NOUN
gra-2158	49	5	,	,	PUNCT
gra-2158	49	6	which	which	PRON
gra-2158	49	7	is	be	AUX
gra-2158	49	8	an	an	DET
gra-2158	49	9	insulinotropic	insulinotropic	NOUN
gra-2158	49	10	hormone	hormone	NOUN
gra-2158	49	11	,	,	PUNCT
gra-2158	49	12	enhances	enhance	VERB
gra-2158	49	13	insulin	insulin	NOUN
gra-2158	49	14	secretion	secretion	NOUN
gra-2158	49	15	and	and	CCONJ
gra-2158	49	16	insulin	insulin	NOUN
gra-2158	49	17	sensitivity	sensitivity	NOUN
gra-2158	49	18	.	.	PUNCT
gra-2158	50	1	it	it	PRON
gra-2158	50	2	also	also	ADV
gra-2158	50	3	delays	delay	VERB
gra-2158	50	4	the	the	DET
gra-2158	50	5	absorption	absorption	NOUN
gra-2158	50	6	as	as	ADV
gra-2158	50	7	well	well	ADV
gra-2158	50	8	as	as	ADP
gra-2158	50	9	digestion	digestion	NOUN
gra-2158	50	10	of	of	ADP
gra-2158	50	11	dietary	dietary	ADJ
gra-2158	50	12	polysaccharides	polysaccharide	NOUN
gra-2158	50	13	by	by	ADP
gra-2158	50	14	reversibly	reversibly	ADV
gra-2158	50	15	inhibiting	inhibit	VERB
gra-2158	50	16	carbohydrate	carbohydrate	ADJ
gra-2158	50	17	digestive	digestive	ADJ
gra-2158	50	18	enzymes	enzyme	NOUN
gra-2158	50	19	.	.	PUNCT
gra-2158	51	1	voglibose	voglibose	NOUN
gra-2158	51	2	has	have	AUX
gra-2158	51	3	shown	show	VERB
gra-2158	51	4	to	to	PART
gra-2158	51	5	improve	improve	VERB
gra-2158	51	6	glucose	glucose	NOUN
gra-2158	51	7	tolerance	tolerance	NOUN
gra-2158	51	8	by	by	ADP
gra-2158	51	9	inhibiting	inhibit	VERB
gra-2158	51	10	digestion	digestion	NOUN
gra-2158	51	11	,	,	PUNCT
gra-2158	51	12	absorption	absorption	NOUN
gra-2158	51	13	of	of	ADP
gra-2158	51	14	glucose	glucose	NOUN
gra-2158	51	15	from	from	ADP
gra-2158	51	16	the	the	DET
gra-2158	51	17	intestine	intestine	NOUN
gra-2158	51	18	and	and	CCONJ
gra-2158	51	19	decrease	decrease	VERB
gra-2158	51	20	postprandial	postprandial	ADJ
gra-2158	51	21	glucose	glucose	NOUN
gra-2158	51	22	without	without	ADP
gra-2158	51	23	8inducing	8induce	VERB
gra-2158	51	24	over	over	ADP
gra-2158	51	25	secretion	secretion	NOUN
gra-2158	51	26	of	of	ADP
gra-2158	51	27	insulin	insulin	NOUN
gra-2158	51	28	.	.	PUNCT
gra-2158	52	1	trials	trial	NOUN
gra-2158	52	2	have	have	AUX
gra-2158	52	3	established	establish	VERB
gra-2158	52	4	the	the	DET
gra-2158	52	5	efcacy	efcacy	NOUN
gra-2158	52	6	of	of	ADP
gra-2158	52	7	the	the	DET
gra-2158	52	8	combination	combination	NOUN
gra-2158	52	9	of	of	ADP
gra-2158	52	10	voglibose	voglibose	NOUN
gra-2158	52	11	and	and	CCONJ
gra-2158	52	12	metformin	metformin	NOUN
gra-2158	52	13	.	.	PUNCT
gra-2158	53	1	oh	oh	INTJ
gra-2158	53	2	et	et	NOUN
gra-2158	53	3	al	al	PROPN
gra-2158	53	4	.	.	PROPN
gra-2158	53	5	,	,	PUNCT
gra-2158	53	6	compared	compare	VERB
gra-2158	53	7	the	the	DET
gra-2158	53	8	efcacy	efcacy	NOUN
gra-2158	53	9	and	and	CCONJ
gra-2158	53	10	safety	safety	NOUN
gra-2158	53	11	of	of	ADP
gra-2158	53	12	a	a	DET
gra-2158	53	13	xed	xe	VERB
gra-2158	53	14	-	-	PUNCT
gra-2158	53	15	dose	dose	NOUN
gra-2158	53	16	combination	combination	NOUN
gra-2158	53	17	of	of	ADP
gra-2158	53	18	voglibose	voglibose	NOUN
gra-2158	53	19	plus	plus	CCONJ
gra-2158	53	20	metformin	metformin	NOUN
gra-2158	53	21	(	(	PUNCT
gra-2158	53	22	vogmet	vogmet	PROPN
gra-2158	53	23	)	)	PUNCT
gra-2158	53	24	with	with	ADP
gra-2158	53	25	metformin	metformin	NOUN
gra-2158	53	26	monotherapy	monotherapy	NOUN
gra-2158	53	27	in	in	ADP
gra-2158	53	28	drugnaïve	drugnaïve	NOUN
gra-2158	53	29	newly	newly	ADV
gra-2158	53	30	-	-	PUNCT
gra-2158	53	31	diagnosed	diagnose	VERB
gra-2158	53	32	type	type	NOUN
gra-2158	53	33	2	2	NUM
gra-2158	53	34	diabetes	diabetes	NOUN
gra-2158	53	35	mellitus	mellitus	NOUN
gra-2158	53	36	.	.	PUNCT
gra-2158	54	1	a	a	DET
gra-2158	54	2	total	total	NOUN
gra-2158	54	3	of	of	ADP
gra-2158	54	4	187	187	NUM
gra-2158	54	5	eligible	eligible	ADJ
gra-2158	54	6	patients	patient	NOUN
gra-2158	54	7	aged	age	VERB
gra-2158	54	8	20	20	NUM
gra-2158	54	9	to	to	PART
gra-2158	54	10	70	70	NUM
gra-2158	54	11	years	year	NOUN
gra-2158	54	12	,	,	PUNCT
gra-2158	54	13	with	with	ADP
gra-2158	54	14	a	a	DET
gra-2158	54	15	glycosylated	glycosylated	ADJ
gra-2158	54	16	hemoglobin	hemoglobin	NOUN
gra-2158	54	17	(	(	PUNCT
gra-2158	54	18	hba1c	hba1c	NOUN
gra-2158	54	19	)	)	PUNCT
gra-2158	54	20	level	level	NOUN
gra-2158	54	21	of	of	ADP
gra-2158	54	22	7.0	7.0	NUM
gra-2158	54	23	%	%	NOUN
gra-2158	54	24	to	to	ADP
gra-2158	54	25	11.0	11.0	NUM
gra-2158	54	26	%	%	NOUN
gra-2158	54	27	,	,	PUNCT
gra-2158	54	28	were	be	AUX
gra-2158	54	29	randomized	randomize	VERB
gra-2158	54	30	into	into	ADP
gra-2158	54	31	either	either	PRON
gra-2158	54	32	vogmet	vogmet	PROPN
gra-2158	54	33	or	or	CCONJ
gra-2158	54	34	metformin	metformin	NOUN
gra-2158	54	35	treatments	treatment	NOUN
gra-2158	54	36	for	for	ADP
gra-2158	54	37	24	24	NUM
gra-2158	54	38	weeks	week	NOUN
gra-2158	54	39	.	.	PUNCT
gra-2158	55	1	a	a	DET
gra-2158	55	2	change	change	NOUN
gra-2158	55	3	in	in	ADP
gra-2158	55	4	the	the	DET
gra-2158	55	5	hba1c	hba1c	PROPN
gra-2158	55	6	level	level	NOUN
gra-2158	55	7	from	from	ADP
gra-2158	55	8	baseline	baseline	NOUN
gra-2158	55	9	was	be	AUX
gra-2158	55	10	measured	measure	VERB
gra-2158	55	11	at	at	ADP
gra-2158	55	12	week	week	NOUN
gra-2158	55	13	24	24	NUM
gra-2158	55	14	.	.	PUNCT
gra-2158	56	1	the	the	DET
gra-2158	56	2	reduction	reduction	NOUN
gra-2158	56	3	in	in	ADP
gra-2158	56	4	the	the	DET
gra-2158	56	5	levels	level	NOUN
gra-2158	56	6	of	of	ADP
gra-2158	56	7	hba1c	hba1c	PROPN
gra-2158	56	8	was	be	AUX
gra-2158	56	9	−1.62%±0.07	−1.62%±0.07	X
gra-2158	56	10	%	%	NOUN
gra-2158	56	11	in	in	ADP
gra-2158	56	12	the	the	DET
gra-2158	56	13	vogmet	vogmet	NOUN
gra-2158	56	14	group	group	NOUN
gra-2158	56	15	and	and	CCONJ
gra-2158	56	16	−1.31%±0.07	−1.31%±0.07	NOUN
gra-2158	56	17	%	%	NOUN
gra-2158	56	18	in	in	ADP
gra-2158	56	19	the	the	DET
gra-2158	56	20	metformin	metformin	NOUN
gra-2158	56	21	group	group	NOUN
gra-2158	56	22	(	(	PUNCT
gra-2158	56	23	p=0.003	p=0.003	NOUN
gra-2158	56	24	)	)	PUNCT
gra-2158	56	25	,	,	PUNCT
gra-2158	56	26	and	and	CCONJ
gra-2158	56	27	signicantly	signicantly	ADV
gra-2158	56	28	more	more	ADV
gra-2158	56	29	vogmet	vogmet	NOUN
gra-2158	56	30	-	-	PUNCT
gra-2158	56	31	treated	treat	VERB
gra-2158	56	32	patients	patient	NOUN
gra-2158	56	33	achieved	achieve	VERB
gra-2158	56	34	the	the	DET
gra-2158	56	35	target	target	NOUN
gra-2158	56	36	hba1c	hba1c	PROPN
gra-2158	56	37	levels	level	NOUN
gra-2158	56	38	of	of	ADP
gra-2158	56	39	<	<	X
gra-2158	56	40	6.5	6.5	NUM
gra-2158	56	41	%	%	NOUN
gra-2158	56	42	(	(	PUNCT
gra-2158	56	43	p=0.002	p=0.002	NOUN
gra-2158	56	44	)	)	PUNCT
gra-2158	56	45	or	or	CCONJ
gra-2158	56	46	<	<	X
gra-2158	56	47	7	7	NUM
gra-2158	56	48	%	%	NOUN
gra-2158	56	49	(	(	PUNCT
gra-2158	56	50	p=0.039	p=0.039	NOUN
gra-2158	56	51	)	)	PUNCT
gra-2158	56	52	.	.	PUNCT
gra-2158	57	1	glycemic	glycemic	ADJ
gra-2158	57	2	variability	variability	NOUN
gra-2158	57	3	was	be	AUX
gra-2158	57	4	also	also	ADV
gra-2158	57	5	signicantly	signicantly	ADV
gra-2158	57	6	improved	improve	VERB
gra-2158	57	7	with	with	ADP
gra-2158	57	8	vogmet	vogmet	NOUN
gra-2158	57	9	treatment	treatment	NOUN
gra-2158	57	10	,	,	PUNCT
gra-2158	57	11	as	as	SCONJ
gra-2158	57	12	estimated	estimate	VERB
gra-2158	57	13	by	by	ADP
gra-2158	57	14	m	m	NOUN
gra-2158	57	15	-	-	PUNCT
gra-2158	57	16	values	value	NOUN
gra-2158	57	17	(	(	PUNCT
gra-2158	57	18	p=0.004	p=0.004	NOUN
gra-2158	57	19	)	)	PUNCT
gra-2158	57	20	.	.	PUNCT
gra-2158	58	1	gastrointestinal	gastrointestinal	ADJ
gra-2158	58	2	adverse	adverse	ADJ
gra-2158	58	3	events	event	NOUN
gra-2158	58	4	and	and	CCONJ
gra-2158	58	5	hypoglycemia	hypoglycemia	NOUN
gra-2158	58	6	(	(	PUNCT
gra-2158	58	7	%	%	INTJ
gra-2158	58	8	)	)	PUNCT
gra-2158	58	9	were	be	AUX
gra-2158	58	10	numerically	numerically	ADV
gra-2158	58	11	lower	low	ADJ
gra-2158	58	12	in	in	ADP
gra-2158	58	13	the	the	DET
gra-2158	58	14	vogmet	vogmet	NOUN
gra-2158	58	15	-	-	PUNCT
gra-2158	58	16	treated	treat	VERB
gra-2158	58	17	group	group	NOUN
gra-2158	58	18	.	.	PUNCT
gra-2158	59	1	moreover	moreover	ADV
gra-2158	59	2	,	,	PUNCT
gra-2158	59	3	a	a	DET
gra-2158	59	4	signicant	signicant	ADJ
gra-2158	59	5	weight	weight	NOUN
gra-2158	59	6	loss	loss	NOUN
gra-2158	59	7	was	be	AUX
gra-2158	59	8	observed	observe	VERB
gra-2158	59	9	with	with	ADP
gra-2158	59	10	vogmet	vogmet	NOUN
gra-2158	59	11	treatment	treatment	NOUN
gra-2158	59	12	compared	compare	VERB
gra-2158	59	13	with	with	ADP
gra-2158	59	14	metformin	metformin	NOUN
gra-2158	59	15	(	(	PUNCT
gra-2158	59	16	−1.63	−1.63	INTJ
gra-2158	59	17	kg	kg	X
gra-2158	59	18	vs.	vs.	ADP
gra-2158	59	19	−0.86	−0.86	NOUN
gra-2158	59	20	kg	kg	PROPN
gra-2158	59	21	,	,	PUNCT
gra-2158	59	22	p=0.039	p=0.039	NOUN
gra-2158	59	23	)	)	PUNCT
gra-2158	59	24	.	.	PUNCT
gra-2158	60	1	it	it	PRON
gra-2158	60	2	was	be	AUX
gra-2158	60	3	concluded	conclude	VERB
gra-2158	60	4	that	that	SCONJ
gra-2158	60	5	vogmet	vogmet	PROPN
gra-2158	60	6	is	be	AUX
gra-2158	60	7	a	a	DET
gra-2158	60	8	safe	safe	ADJ
gra-2158	60	9	antihyperglycemic	antihyperglycemic	ADJ
gra-2158	60	10	agent	agent	NOUN
gra-2158	60	11	that	that	PRON
gra-2158	60	12	controls	control	VERB
gra-2158	60	13	blood	blood	NOUN
gra-2158	60	14	glucose	glucose	NOUN
gra-2158	60	15	level	level	NOUN
gra-2158	60	16	effectively	effectively	ADV
gra-2158	60	17	,	,	PUNCT
gra-2158	60	18	yields	yield	VERB
gra-2158	60	19	weight	weight	NOUN
gra-2158	60	20	loss	loss	NOUN
gra-2158	60	21	,	,	PUNCT
gra-2158	60	22	and	and	CCONJ
gra-2158	60	23	is	be	AUX
gra-2158	60	24	superior	superior	ADJ
gra-2158	60	25	to	to	ADP
gra-2158	60	26	metformin	metformin	NOUN
gra-2158	60	27	in	in	ADP
gra-2158	60	28	terms	term	NOUN
gra-2158	60	29	of	of	ADP
gra-2158	60	30	various	various	ADJ
gra-2158	60	31	key	key	ADJ
gra-2158	60	32	glycemic	glycemic	ADJ
gra-2158	60	33	parameters	parameter	NOUN
gra-2158	60	34	9without	9without	NUM
gra-2158	60	35	increasing	increase	VERB
gra-2158	60	36	the	the	DET
gra-2158	60	37	risk	risk	NOUN
gra-2158	60	38	of	of	ADP
gra-2158	60	39	hypoglycemia	hypoglycemia	NOUN
gra-2158	60	40	.	.	PUNCT
gra-2158	61	1	faruqui	faruqui	NOUN
gra-2158	61	2	.	.	PUNCT
gra-2158	61	3	,	,	PUNCT
gra-2158	61	4	carried	carry	VERB
gra-2158	61	5	out	out	ADP
gra-2158	61	6	post	post	ADJ
gra-2158	61	7	-	-	ADJ
gra-2158	61	8	marketing	marketing	ADJ
gra-2158	61	9	surveillance	surveillance	NOUN
gra-2158	61	10	(	(	PUNCT
gra-2158	61	11	pms	pms	PROPN
gra-2158	61	12	)	)	PUNCT
gra-2158	61	13	,	,	PUNCT
gra-2158	61	14	non	non	ADJ
gra-2158	61	15	-	-	ADJ
gra-2158	61	16	randomized	randomized	ADJ
gra-2158	61	17	,	,	PUNCT
gra-2158	61	18	open	open	ADJ
gra-2158	61	19	,	,	PUNCT
gra-2158	61	20	non	non	ADJ
gra-2158	61	21	-	-	ADJ
gra-2158	61	22	comparative	comparative	ADJ
gra-2158	61	23	,	,	PUNCT
gra-2158	61	24	mono	mono	NOUN
gra-2158	61	25	-	-	PUNCT
gra-2158	61	26	centric	centric	ADJ
gra-2158	61	27	study	study	NOUN
gra-2158	61	28	.	.	PUNCT
gra-2158	62	1	the	the	DET
gra-2158	62	2	drug	drug	NOUN
gra-2158	62	3	administered	administer	VERB
gra-2158	62	4	was	be	AUX
gra-2158	62	5	a	a	DET
gra-2158	62	6	xed	xe	VERB
gra-2158	62	7	-	-	PUNCT
gra-2158	62	8	dose	dose	NOUN
gra-2158	62	9	combination	combination	NOUN
gra-2158	62	10	of	of	ADP
gra-2158	62	11	voglibose	voglibose	NOUN
gra-2158	62	12	0.2	0.2	NUM
gra-2158	62	13	mg	mg	NUM
gra-2158	62	14	;	;	PUNCT
gra-2158	62	15	glimepiride	glimepiride	NOUN
gra-2158	62	16	,	,	PUNCT
gra-2158	62	17	0.5	0.5	NUM
gra-2158	62	18	mg	mg	NOUN
gra-2158	62	19	,	,	PUNCT
gra-2158	62	20	and	and	CCONJ
gra-2158	62	21	metformin	metformin	NOUN
gra-2158	62	22	500	500	NUM
gra-2158	62	23	mg	mg	PROPN
gra-2158	62	24	sustainedrelease	sustainedrelease	PROPN
gra-2158	62	25	(	(	PUNCT
gra-2158	62	26	sr	sr	PROPN
gra-2158	62	27	)	)	PUNCT
gra-2158	62	28	.	.	PUNCT
gra-2158	63	1	fifty	fifty	NUM
gra-2158	63	2	type	type	NOUN
gra-2158	63	3	2	2	NUM
gra-2158	63	4	diabetic	diabetic	ADJ
gra-2158	63	5	patients	patient	NOUN
gra-2158	63	6	were	be	AUX
gra-2158	63	7	given	give	VERB
gra-2158	63	8	a	a	DET
gra-2158	63	9	xeddose	xeddose	ADJ
gra-2158	63	10	combination	combination	NOUN
gra-2158	63	11	twice	twice	ADV
gra-2158	63	12	daily	daily	ADV
gra-2158	63	13	with	with	ADP
gra-2158	63	14	major	major	ADJ
gra-2158	63	15	meals	meal	NOUN
gra-2158	63	16	for	for	ADP
gra-2158	63	17	3	3	NUM
gra-2158	63	18	months	month	NOUN
gra-2158	63	19	.	.	PUNCT
gra-2158	64	1	baseline	baseline	PROPN
gra-2158	64	2	value	value	NOUN
gra-2158	64	3	was	be	AUX
gra-2158	64	4	recorded	record	VERB
gra-2158	64	5	for	for	ADP
gra-2158	64	6	glycated	glycate	VERB
gra-2158	64	7	hemoglobin	hemoglobin	NOUN
gra-2158	64	8	(	(	PUNCT
gra-2158	64	9	hba1c	hba1c	PROPN
gra-2158	64	10	)	)	PUNCT
gra-2158	64	11	,	,	PUNCT
gra-2158	64	12	fasting	fast	VERB
gra-2158	64	13	plasma	plasma	NOUN
gra-2158	64	14	glucose	glucose	NOUN
gra-2158	64	15	(	(	PUNCT
gra-2158	64	16	fpg	fpg	PROPN
gra-2158	64	17	)	)	PUNCT
gra-2158	64	18	and	and	CCONJ
gra-2158	64	19	postprandial	postprandial	ADJ
gra-2158	64	20	blood	blood	NOUN
gra-2158	64	21	glucose	glucose	NOUN
gra-2158	64	22	/	/	SYM
gra-2158	64	23	hyperglycemia	hyperglycemia	NOUN
gra-2158	64	24	(	(	PUNCT
gra-2158	64	25	pphg	pphg	ADJ
gra-2158	64	26	)	)	PUNCT
gra-2158	64	27	level	level	NOUN
gra-2158	64	28	.	.	PUNCT
gra-2158	65	1	it	it	PRON
gra-2158	65	2	was	be	AUX
gra-2158	65	3	found	find	VERB
gra-2158	65	4	that	that	SCONJ
gra-2158	65	5	there	there	PRON
gra-2158	65	6	was	be	VERB
gra-2158	65	7	a	a	DET
gra-2158	65	8	signicant	signicant	ADJ
gra-2158	65	9	decrease	decrease	NOUN
gra-2158	65	10	from	from	ADP
gra-2158	65	11	baseline	baseline	NOUN
gra-2158	65	12	in	in	ADP
gra-2158	65	13	hba1c	hba1c	PROPN
gra-2158	65	14	value	value	NOUN
gra-2158	65	15	10.6	10.6	NUM
gra-2158	65	16	±	±	NUM
gra-2158	65	17	1.3	1.3	NUM
gra-2158	65	18	vs.	vs.	ADP
gra-2158	65	19	6.6	6.6	NUM
gra-2158	65	20	±	±	NUM
gra-2158	65	21	0.4	0.4	NUM
gra-2158	65	22	(	(	PUNCT
gra-2158	65	23	p	p	X
gra-2158	65	24	<	<	X
gra-2158	65	25	0.0001	0.0001	NUM
gra-2158	65	26	)	)	PUNCT
gra-2158	65	27	,	,	PUNCT
gra-2158	65	28	fpg	fpg	PROPN
gra-2158	65	29	levels	level	NOUN
gra-2158	65	30	208.33mg	208.33mg	ADV
gra-2158	65	31	/	/	SYM
gra-2158	65	32	dl	dl	PROPN
gra-2158	65	33	vs.	vs.	ADP
gra-2158	65	34	118.06	118.06	NUM
gra-2158	65	35	(	(	PUNCT
gra-2158	65	36	p	p	X
gra-2158	65	37	<	<	X
gra-2158	65	38	0.0001	0.0001	NUM
gra-2158	65	39	)	)	PUNCT
gra-2158	65	40	,	,	PUNCT
gra-2158	65	41	and	and	CCONJ
gra-2158	65	42	pphg	pphg	ADJ
gra-2158	65	43	levels	level	NOUN
gra-2158	65	44	360.14	360.14	NUM
gra-2158	65	45	mg	mg	PROPN
gra-2158	65	46	/	/	SYM
gra-2158	65	47	dl	dl	PROPN
gra-2158	65	48	vs.	vs.	ADP
gra-2158	65	49	168.36	168.36	NUM
gra-2158	65	50	,	,	PUNCT
gra-2158	65	51	(	(	PUNCT
gra-2158	65	52	p	p	X
gra-2158	65	53	<	<	X
gra-2158	65	54	0.0001	0.0001	NUM
gra-2158	65	55	)	)	PUNCT
gra-2158	65	56	after	after	ADP
gra-2158	65	57	3	3	NUM
gra-2158	65	58	months	month	NOUN
gra-2158	65	59	of	of	ADP
gra-2158	65	60	treatment	treatment	NOUN
gra-2158	65	61	.	.	PUNCT
gra-2158	66	1	the	the	DET
gra-2158	66	2	combination	combination	NOUN
gra-2158	66	3	was	be	AUX
gra-2158	66	4	found	find	VERB
gra-2158	66	5	to	to	PART
gra-2158	66	6	be	be	AUX
gra-2158	66	7	effective	effective	ADJ
gra-2158	66	8	in	in	ADP
gra-2158	66	9	controlling	control	VERB
gra-2158	66	10	both	both	PRON
gra-2158	66	11	fasting	fast	VERB
gra-2158	66	12	and	and	CCONJ
gra-2158	66	13	postprandial	postprandial	ADJ
gra-2158	66	14	glucose	glucose	NOUN
gra-2158	66	15	levels	level	NOUN
gra-2158	66	16	and	and	CCONJ
gra-2158	66	17	was	be	AUX
gra-2158	66	18	well	well	ADV
gra-2158	66	19	tolerated	tolerate	VERB
gra-2158	66	20	.	.	PUNCT
gra-2158	67	1	investigator	investigator	NOUN
gra-2158	67	2	commented	comment	VERB
gra-2158	67	3	that	that	SCONJ
gra-2158	67	4	the	the	DET
gra-2158	67	5	use	use	NOUN
gra-2158	67	6	of	of	ADP
gra-2158	67	7	triple	triple	ADJ
gra-2158	67	8	-	-	PUNCT
gra-2158	67	9	drug	drug	NOUN
gra-2158	67	10	combination	combination	NOUN
gra-2158	67	11	is	be	AUX
gra-2158	67	12	a	a	DET
gra-2158	67	13	good	good	ADJ
gra-2158	67	14	option	option	NOUN
gra-2158	67	15	in	in	ADP
gra-2158	67	16	the	the	DET
gra-2158	67	17	management	management	NOUN
gra-2158	67	18	of	of	ADP
gra-2158	67	19	type	type	NOUN
gra-2158	67	20	2	2	NUM
gra-2158	67	21	diabetes	diabetes	NOUN
gra-2158	67	22	which	which	PRON
gra-2158	67	23	controls	control	VERB
gra-2158	67	24	both	both	DET
gra-2158	67	25	fasting	fast	VERB
gra-2158	67	26	as	as	ADV
gra-2158	67	27	well	well	ADV
gra-2158	67	28	as	as	ADP
gra-2158	67	29	postprandial	postprandial	ADJ
gra-2158	67	30	10blood	10blood	DET
gra-2158	67	31	glucose	glucose	NOUN
gra-2158	67	32	and	and	CCONJ
gra-2158	67	33	ultimately	ultimately	ADV
gra-2158	67	34	hba1c	hba1c	ADJ
gra-2158	67	35	values	value	NOUN
gra-2158	67	36	.	.	PUNCT
gra-2158	68	1	conclusion	conclusion	NOUN
gra-2158	68	2	metformin	metformin	NOUN
gra-2158	68	3	has	have	AUX
gra-2158	68	4	been	be	AUX
gra-2158	68	5	the	the	DET
gra-2158	68	6	mainstay	mainstay	NOUN
gra-2158	68	7	and	and	CCONJ
gra-2158	68	8	rst	rst	PROPN
gra-2158	68	9	-	-	PUNCT
gra-2158	68	10	line	line	NOUN
gra-2158	68	11	treatment	treatment	NOUN
gra-2158	68	12	for	for	ADP
gra-2158	68	13	the	the	DET
gra-2158	68	14	management	management	NOUN
gra-2158	68	15	of	of	ADP
gra-2158	68	16	type	type	NOUN
gra-2158	68	17	2	2	NUM
gra-2158	68	18	diabetes	diabetes	NOUN
gra-2158	68	19	.	.	PUNCT
gra-2158	69	1	however	however	ADV
gra-2158	69	2	,	,	PUNCT
gra-2158	69	3	the	the	DET
gra-2158	69	4	management	management	NOUN
gra-2158	69	5	of	of	ADP
gra-2158	69	6	type	type	NOUN
gra-2158	69	7	2	2	NUM
gra-2158	69	8	diabetes	diabetes	NOUN
gra-2158	69	9	often	often	ADV
gra-2158	69	10	requires	require	VERB
gra-2158	69	11	a	a	DET
gra-2158	69	12	combination	combination	NOUN
gra-2158	69	13	of	of	ADP
gra-2158	69	14	antidiabetic	antidiabetic	ADJ
gra-2158	69	15	agents	agent	NOUN
gra-2158	69	16	.	.	PUNCT
gra-2158	70	1	for	for	ADP
gra-2158	70	2	the	the	DET
gra-2158	70	3	successful	successful	ADJ
gra-2158	70	4	management	management	NOUN
gra-2158	70	5	of	of	ADP
gra-2158	70	6	both	both	DET
gra-2158	70	7	insulin	insulin	NOUN
gra-2158	70	8	resistance	resistance	NOUN
gra-2158	70	9	and	and	CCONJ
gra-2158	70	10	�	�	PROPN
gra-2158	70	11	cell	cell	NOUN
gra-2158	70	12	dysfunction	dysfunction	NOUN
gra-2158	70	13	,	,	PUNCT
gra-2158	70	14	there	there	PRON
gra-2158	70	15	arises	arise	VERB
gra-2158	70	16	a	a	DET
gra-2158	70	17	need	need	NOUN
gra-2158	70	18	for	for	ADP
gra-2158	70	19	combination	combination	NOUN
gra-2158	70	20	therapy	therapy	NOUN
gra-2158	70	21	with	with	ADP
gra-2158	70	22	agents	agent	NOUN
gra-2158	70	23	having	have	VERB
gra-2158	70	24	complementary	complementary	ADJ
gra-2158	70	25	mechanisms	mechanism	NOUN
gra-2158	70	26	of	of	ADP
gra-2158	70	27	action	action	NOUN
gra-2158	70	28	.	.	PUNCT
gra-2158	71	1	the	the	DET
gra-2158	71	2	outcome	outcome	NOUN
gra-2158	71	3	of	of	ADP
gra-2158	71	4	clinical	clinical	ADJ
gra-2158	71	5	trials	trial	NOUN
gra-2158	71	6	like	like	ADP
gra-2158	71	7	ukpds	ukpds	PROPN
gra-2158	71	8	laid	lay	VERB
gra-2158	71	9	the	the	DET
gra-2158	71	10	basis	basis	NOUN
gra-2158	71	11	of	of	ADP
gra-2158	71	12	usage	usage	NOUN
gra-2158	71	13	of	of	ADP
gra-2158	71	14	metformin	metformin	NOUN
gra-2158	71	15	along	along	ADP
gra-2158	71	16	with	with	ADP
gra-2158	71	17	glimepiride	glimepiride	NOUN
gra-2158	71	18	.	.	PUNCT
gra-2158	72	1	to	to	PART
gra-2158	72	2	further	far	ADV
gra-2158	72	3	maintain	maintain	VERB
gra-2158	72	4	glycemic	glycemic	ADJ
gra-2158	72	5	control	control	NOUN
gra-2158	72	6	,	,	PUNCT
gra-2158	72	7	a	a	DET
gra-2158	72	8	triple	triple	ADJ
gra-2158	72	9	combination	combination	NOUN
gra-2158	72	10	of	of	ADP
gra-2158	72	11	voglibose	voglibose	NOUN
gra-2158	72	12	and	and	CCONJ
gra-2158	72	13	metformin	metformin	PROPN
gra-2158	72	14	&	&	CCONJ
gra-2158	72	15	glimepiride	glimepiride	PROPN
gra-2158	72	16	has	have	AUX
gra-2158	72	17	been	be	AUX
gra-2158	72	18	proposed	propose	VERB
gra-2158	72	19	.	.	PUNCT
gra-2158	73	1	trials	trial	NOUN
gra-2158	73	2	have	have	AUX
gra-2158	73	3	conrmed	conrme	VERB
gra-2158	73	4	the	the	DET
gra-2158	73	5	efcacy	efcacy	NOUN
gra-2158	73	6	and	and	CCONJ
gra-2158	73	7	safety	safety	NOUN
gra-2158	73	8	of	of	ADP
gra-2158	73	9	this	this	DET
gra-2158	73	10	triple	triple	ADJ
gra-2158	73	11	combination	combination	NOUN
gra-2158	73	12	,	,	PUNCT
gra-2158	73	13	though	though	SCONJ
gra-2158	73	14	large	large	ADJ
gra-2158	73	15	scale	scale	NOUN
gra-2158	73	16	trials	trial	NOUN
gra-2158	73	17	are	be	AUX
gra-2158	73	18	needed	need	VERB
gra-2158	73	19	.	.	PUNCT
gra-2158	74	1	used	use	VERB
gra-2158	74	2	wisely	wisely	ADV
gra-2158	74	3	,	,	PUNCT
gra-2158	74	4	with	with	ADP
gra-2158	74	5	adequate	adequate	ADJ
gra-2158	74	6	medication	medication	NOUN
gra-2158	74	7	counseling	counseling	NOUN
gra-2158	74	8	,	,	PUNCT
gra-2158	74	9	triple	triple	ADJ
gra-2158	74	10	fdcs	fdc	NOUN
gra-2158	74	11	provide	provide	VERB
gra-2158	74	12	effective	effective	ADJ
gra-2158	74	13	glycemic	glycemic	ADJ
gra-2158	74	14	control	control	NOUN
gra-2158	74	15	in	in	ADP
gra-2158	74	16	a	a	DET
gra-2158	74	17	safe	safe	ADJ
gra-2158	74	18	,	,	PUNCT
gra-2158	74	19	welltolerated	welltolerate	VERB
gra-2158	74	20	,	,	PUNCT
gra-2158	74	21	and	and	CCONJ
gra-2158	74	22	economic	economic	ADJ
gra-2158	74	23	manner	manner	NOUN
gra-2158	74	24	.	.	PUNCT
gra-2158	75	1	references	reference	NOUN
gra-2158	75	2	1	1	NUM
gra-2158	75	3	.	.	PUNCT
gra-2158	75	4	sharma	sharma	PROPN
gra-2158	75	5	ak	ak	PROPN
gra-2158	75	6	,	,	PUNCT
gra-2158	75	7	srinivasan	srinivasan	PROPN
gra-2158	75	8	bp	bp	PROPN
gra-2158	75	9	.	.	PUNCT
gra-2158	76	1	triple	triple	ADJ
gra-2158	76	2	verses	verses	ADP
gra-2158	76	3	glimepiride	glimepiride	NOUN
gra-2158	76	4	plus	plus	CCONJ
gra-2158	76	5	metformin	metformin	NOUN
gra-2158	76	6	therapy	therapy	NOUN
gra-2158	76	7	on	on	ADP
gra-2158	76	8	cardiovascular	cardiovascular	ADJ
gra-2158	76	9	risk	risk	NOUN
gra-2158	76	10	biomarkers	biomarker	NOUN
gra-2158	76	11	and	and	CCONJ
gra-2158	76	12	diabetic	diabetic	ADJ
gra-2158	76	13	cardiomyopathy	cardiomyopathy	ADJ
gra-2158	76	14	in	in	ADP
gra-2158	76	15	insulin	insulin	NOUN
gra-2158	76	16	resistance	resistance	NOUN
gra-2158	76	17	type	type	NOUN
gra-2158	76	18	2	2	NUM
gra-2158	76	19	diabetes	diabetes	NOUN
gra-2158	76	20	mellitus	mellitus	NOUN
gra-2158	76	21	rats	rat	NOUN
gra-2158	76	22	.	.	PUNCT
gra-2158	77	1	eur	eur	PROPN
gra-2158	77	2	j	j	PROPN
gra-2158	77	3	pharm	pharm	PROPN
gra-2158	77	4	sci	sci	PROPN
gra-2158	77	5	.	.	PUNCT
gra-2158	77	6	2009;38(5):433	2009;38(5):433	PROPN
gra-2158	77	7	-	-	PUNCT
gra-2158	77	8	444	444	NUM
gra-2158	77	9	.	.	PUNCT
gra-2158	77	10	doi:10.1016	doi:10.1016	PROPN
gra-2158	77	11	/	/	SYM
gra-2158	77	12	j.ejps.2009.09.004	j.ejps.2009.09.004	PROPN
gra-2158	77	13	2	2	X
gra-2158	77	14	.	.	PUNCT
gra-2158	78	1	derosa	derosa	PROPN
gra-2158	78	2	g	g	PROPN
gra-2158	78	3	,	,	PUNCT
gra-2158	78	4	putignano	putignano	PROPN
gra-2158	78	5	p	p	X
gra-2158	78	6	,	,	PUNCT
gra-2158	78	7	bossi	bossi	PROPN
gra-2158	78	8	ac	ac	PROPN
gra-2158	78	9	,	,	PUNCT
gra-2158	78	10	et	et	PROPN
gra-2158	78	11	al	al	PROPN
gra-2158	78	12	.	.	PROPN
gra-2158	78	13	exenatide	exenatide	PROPN
gra-2158	78	14	or	or	CCONJ
gra-2158	78	15	glimepiride	glimepiride	NOUN
gra-2158	78	16	added	add	VERB
gra-2158	78	17	to	to	ADP
gra-2158	78	18	metformin	metformin	NOUN
gra-2158	78	19	on	on	ADP
gra-2158	78	20	metabolic	metabolic	NOUN
gra-2158	78	21	control	control	NOUN
gra-2158	78	22	and	and	CCONJ
gra-2158	78	23	on	on	ADP
gra-2158	78	24	insulin	insulin	NOUN
gra-2158	78	25	resistance	resistance	NOUN
gra-2158	78	26	in	in	ADP
gra-2158	78	27	type	type	NOUN
gra-2158	78	28	2	2	NUM
gra-2158	78	29	diabetic	diabetic	ADJ
gra-2158	78	30	patients	patient	NOUN
gra-2158	78	31	.	.	PUNCT
gra-2158	79	1	eur	eur	PROPN
gra-2158	79	2	j	j	PROPN
gra-2158	79	3	pharmacol	pharmacol	PROPN
gra-2158	79	4	.	.	PUNCT
gra-2158	80	1	2011;666(1	2011;666(1	NUM
gra-2158	80	2	-	-	PUNCT
gra-2158	80	3	3):251	3):251	NUM
gra-2158	80	4	-	-	PUNCT
gra-2158	80	5	256	256	NUM
gra-2158	80	6	.	.	PUNCT
gra-2158	81	1	doi:10.1016	doi:10.1016	PROPN
gra-2158	81	2	/	/	SYM
gra-2158	81	3	j.ej	j.ej	PROPN
gra-2158	81	4	phar.20	phar.20	NOUN
gra-2158	81	5	11.05.051	11.05.051	PROPN
gra-2158	81	6	3	3	NUM
gra-2158	81	7	.	.	PUNCT
gra-2158	81	8	shin	shin	PROPN
gra-2158	81	9	kh	kh	PROPN
gra-2158	81	10	,	,	PUNCT
gra-2158	81	11	kim	kim	PROPN
gra-2158	81	12	se	se	PROPN
gra-2158	81	13	,	,	PUNCT
gra-2158	81	14	yoon	yoon	PROPN
gra-2158	81	15	sh	sh	PROPN
gra-2158	81	16	,	,	PUNCT
gra-2158	81	17	et	et	PROPN
gra-2158	81	18	al	al	PROPN
gra-2158	81	19	.	.	PUNCT
gra-2158	82	1	pharmacokinetic	pharmacokinetic	ADJ
gra-2158	82	2	comparison	comparison	NOUN
gra-2158	82	3	of	of	ADP
gra-2158	82	4	a	a	DET
gra-2158	82	5	new	new	ADJ
gra-2158	82	6	sustained	sustain	VERB
gra-2158	82	7	-	-	PUNCT
gra-2158	82	8	release	release	NOUN
gra-2158	82	9	formulation	formulation	NOUN
gra-2158	82	10	of	of	ADP
gra-2158	82	11	glimepiride	glimepiride	NOUN
gra-2158	82	12	/	/	SYM
gra-2158	82	13	metformin	metformin	NOUN
gra-2158	82	14	1/500	1/500	NUM
gra-2158	82	15	mg	mg	PROPN
gra-2158	82	16	combination	combination	NOUN
gra-2158	82	17	tablet	tablet	NOUN
gra-2158	82	18	and	and	CCONJ
gra-2158	82	19	a	a	DET
gra-2158	82	20	sustained	sustain	VERB
gra-2158	82	21	-	-	PUNCT
gra-2158	82	22	release	release	NOUN
gra-2158	82	23	formulation	formulation	NOUN
gra-2158	82	24	of	of	ADP
gra-2158	82	25	glimepiride	glimepiride	NOUN
gra-2158	82	26	/metformin	/metformin	PUNCT
gra-2158	82	27	2/500	2/500	NUM
gra-2158	82	28	mg	mg	PROPN
gra-2158	82	29	combination	combination	NOUN
gra-2158	82	30	tablet	tablet	NOUN
gra-2158	82	31	in	in	ADP
gra-2158	82	32	healthy	healthy	ADJ
gra-2158	82	33	korean	korean	ADJ
gra-2158	82	34	male	male	NOUN
gra-2158	82	35	volunteers	volunteer	NOUN
gra-2158	82	36	:	:	PUNCT
gra-2158	82	37	a	a	DET
gra-2158	82	38	randomized	randomize	VERB
gra-2158	82	39	.	.	PUNCT
gra-2158	83	1	clin	clin	PROPN
gra-2158	83	2	ther	ther	ADV
gra-2158	83	3	.	.	PUNCT
gra-2158	84	1	2011;33(11):1809	2011;33(11):1809	NUM
gra-2158	84	2	-	-	SYM
gra-2158	84	3	1818	1818	NUM
gra-2158	84	4	.	.	PUNCT
gra-2158	85	1	doi:10.1016	doi:10.1016	PROPN
gra-2158	86	1	/j.clin	/j.clin	PROPN
gra-2158	86	2	thera	thera	PROPN
gra-2158	86	3	.2011	.2011	PROPN
gra-2158	86	4	.10.003	.10.003	PUNCT
gra-2158	87	1	4	4	X
gra-2158	87	2	.	.	X
gra-2158	87	3	kim	kim	PROPN
gra-2158	87	4	h	h	PROPN
gra-2158	87	5	soon	soon	ADV
gra-2158	87	6	,	,	PUNCT
gra-2158	87	7	kim	kim	PROPN
gra-2158	87	8	d	d	PROPN
gra-2158	87	9	man	man	PROPN
gra-2158	87	10	,	,	PUNCT
gra-2158	87	11	cha	cha	PROPN
gra-2158	87	12	b	b	PROPN
gra-2158	87	13	soo	soo	PROPN
gra-2158	87	14	,	,	PUNCT
gra-2158	87	15	et	et	PROPN
gra-2158	87	16	al	al	PROPN
gra-2158	87	17	.	.	PROPN
gra-2158	87	18	efcacy	efcacy	NOUN
gra-2158	87	19	of	of	ADP
gra-2158	87	20	glimepiride	glimepiride	NOUN
gra-2158	87	21	/	/	SYM
gra-2158	87	22	metformin	metformin	NOUN
gra-2158	87	23	xed	xe	VERB
gra-2158	87	24	-	-	PUNCT
gra-2158	87	25	dose	dose	NOUN
gra-2158	87	26	combination	combination	NOUN
gra-2158	87	27	vs	vs	ADP
gra-2158	87	28	metformin	metformin	NOUN
gra-2158	87	29	uptitration	uptitration	NOUN
gra-2158	87	30	in	in	ADP
gra-2158	87	31	type	type	NOUN
gra-2158	87	32	2	2	NUM
gra-2158	87	33	diabetic	diabetic	ADJ
gra-2158	87	34	patients	patient	NOUN
gra-2158	87	35	inadequately	inadequately	ADV
gra-2158	87	36	controlled	control	VERB
gra-2158	87	37	on	on	ADP
gra-2158	87	38	low	low	ADJ
gra-2158	87	39	-	-	PUNCT
gra-2158	87	40	dose	dose	NOUN
gra-2158	87	41	metformin	metformin	NOUN
gra-2158	87	42	monotherapy	monotherapy	NOUN
gra-2158	87	43	:	:	PUNCT
gra-2158	87	44	a	a	DET
gra-2158	87	45	randomized	randomized	ADJ
gra-2158	87	46	,	,	PUNCT
gra-2158	87	47	open	open	ADJ
gra-2158	87	48	label	label	NOUN
gra-2158	87	49	,	,	PUNCT
gra-2158	87	50	parallel	parallel	ADJ
gra-2158	87	51	group	group	NOUN
gra-2158	87	52	,	,	PUNCT
gra-2158	87	53	multicenter	multicenter	ADJ
gra-2158	87	54	study	study	NOUN
gra-2158	87	55	in	in	ADP
gra-2158	87	56	korea	korea	PROPN
gra-2158	87	57	.	.	PUNCT
gra-2158	88	1	j	j	PROPN
gra-2158	88	2	diabetes	diabetes	PROPN
gra-2158	88	3	investig	investig	PROPN
gra-2158	88	4	.	.	PROPN
gra-2158	88	5	2014;5(6):701	2014;5(6):701	NUM
gra-2158	88	6	-	-	SYM
gra-2158	88	7	708	708	NUM
gra-2158	88	8	.	.	PUNCT
gra-2158	89	1	doi:10.1111	doi:10.1111	ADJ
gra-2158	89	2	/	/	SYM
gra-2158	89	3	jdi.12201	jdi.12201	NUM
gra-2158	89	4	5	5	NUM
gra-2158	89	5	.	.	PUNCT
gra-2158	89	6	gonzález	gonzález	PROPN
gra-2158	89	7	-	-	PUNCT
gra-2158	89	8	ortiz	ortiz	PROPN
gra-2158	89	9	m	m	PROPN
gra-2158	89	10	,	,	PUNCT
gra-2158	89	11	guerrero	guerrero	PROPN
gra-2158	89	12	-	-	PUNCT
gra-2158	89	13	romero	romero	PROPN
gra-2158	89	14	jf	jf	PROPN
gra-2158	89	15	,	,	PUNCT
gra-2158	89	16	violante	violante	NOUN
gra-2158	89	17	-	-	PUNCT
gra-2158	89	18	ortiz	ortiz	NOUN
gra-2158	89	19	r	r	NOUN
gra-2158	89	20	,	,	PUNCT
gra-2158	89	21	et	et	PROPN
gra-2158	89	22	al	al	PROPN
gra-2158	89	23	.	.	PROPN
gra-2158	89	24	efcacy	efcacy	NOUN
gra-2158	89	25	of	of	ADP
gra-2158	89	26	glimepiride	glimepiride	NOUN
gra-2158	89	27	/	/	SYM
gra-2158	89	28	metformin	metformin	NOUN
gra-2158	89	29	combination	combination	NOUN
gra-2158	89	30	versus	versus	ADP
gra-2158	89	31	glibenclamide	glibenclamide	NOUN
gra-2158	89	32	/	/	SYM
gra-2158	89	33	metformin	metformin	NOUN
gra-2158	89	34	in	in	ADP
gra-2158	89	35	patients	patient	NOUN
gra-2158	89	36	with	with	ADP
gra-2158	89	37	uncontrolled	uncontrolled	ADJ
gra-2158	89	38	type	type	NOUN
gra-2158	89	39	2	2	NUM
gra-2158	89	40	diabetes	diabetes	NOUN
gra-2158	89	41	mellitus	mellitus	NOUN
gra-2158	89	42	.	.	PUNCT
gra-2158	90	1	j	j	PROPN
gra-2158	90	2	diabetes	diabetes	NOUN
gra-2158	90	3	complications	complication	NOUN
gra-2158	90	4	.	.	PUNCT
gra-2158	91	1	2009;23(6):376	2009;23(6):376	NUM
gra-2158	91	2	-	-	SYM
gra-2158	91	3	379	379	NUM
gra-2158	91	4	.	.	PUNCT
gra-2158	91	5	doi:10.1016	doi:10.1016	PROPN
gra-2158	91	6	/	/	SYM
gra-2158	91	7	j.jdiacomp.2008.09.002	j.jdiacomp.2008.09.002	PROPN
gra-2158	91	8	6	6	NUM
gra-2158	91	9	.	.	PUNCT
gra-2158	92	1	park	park	PROPN
gra-2158	92	2	cy	cy	PROPN
gra-2158	92	3	,	,	PUNCT
gra-2158	92	4	kang	kang	PROPN
gra-2158	92	5	jg	jg	PROPN
gra-2158	92	6	,	,	PUNCT
gra-2158	92	7	chon	chon	PROPN
gra-2158	92	8	s	s	PROPN
gra-2158	92	9	,	,	PUNCT
gra-2158	92	10	et	et	PROPN
gra-2158	92	11	al	al	PROPN
gra-2158	92	12	.	.	PROPN
gra-2158	92	13	comparison	comparison	NOUN
gra-2158	92	14	between	between	ADP
gra-2158	92	15	the	the	DET
gra-2158	92	16	therapeutic	therapeutic	ADJ
gra-2158	92	17	effect	effect	NOUN
gra-2158	92	18	of	of	ADP
gra-2158	92	19	metformin	metformin	NOUN
gra-2158	92	20	,	,	PUNCT
gra-2158	92	21	glimepiride	glimepiride	NOUN
gra-2158	92	22	and	and	CCONJ
gra-2158	92	23	their	their	PRON
gra-2158	92	24	combination	combination	NOUN
gra-2158	92	25	as	as	ADP
gra-2158	92	26	an	an	DET
gra-2158	92	27	add	add	VERB
gra-2158	92	28	-	-	PUNCT
gra-2158	92	29	on	on	ADP
gra-2158	92	30	treatment	treatment	NOUN
gra-2158	92	31	to	to	ADP
gra-2158	92	32	insulin	insulin	NOUN
gra-2158	92	33	glargine	glargine	NOUN
gra-2158	92	34	in	in	ADP
gra-2158	92	35	uncontrolled	uncontrolled	ADJ
gra-2158	92	36	patients	patient	NOUN
gra-2158	92	37	with	with	ADP
gra-2158	92	38	type	type	NOUN
gra-2158	92	39	2	2	NUM
gra-2158	92	40	diabetes	diabetes	NOUN
gra-2158	92	41	.	.	PUNCT
gra-2158	93	1	plos	plos	PROPN
gra-2158	93	2	one	one	NUM
gra-2158	93	3	.	.	PUNCT
gra-2158	94	1	volume-9	volume-9	NUM
gra-2158	94	2	,	,	PUNCT
gra-2158	94	3	issue-3	issue-3	NUM
gra-2158	94	4	,	,	PUNCT
gra-2158	94	5	march-2020	march-2020	ADJ
gra-2158	94	6	•	•	NOUN
gra-2158	94	7	print	print	NOUN
gra-2158	94	8	issn	issn	PROPN
gra-2158	94	9	no	no	NOUN
gra-2158	94	10	.	.	PROPN
gra-2158	94	11	2277	2277	NUM
gra-2158	94	12	8160	8160	NUM
gra-2158	94	13	•	•	NOUN
gra-2158	94	14	doi	doi	NOUN
gra-2158	94	15	:	:	PUNCT
gra-2158	94	16	10.36106	10.36106	NUM
gra-2158	94	17	/	/	SYM
gra-2158	94	18	gjra	gjra	NOUN
gra-2158	94	19	2014;9(3	2014;9(3	NUM
gra-2158	94	20	)	)	PUNCT
gra-2158	94	21	.	.	PUNCT
gra-2158	95	1	doi:10.1371	doi:10.1371	PROPN
gra-2158	95	2	/	/	SYM
gra-2158	96	1	journal.pone.0087799	journal.pone.0087799	NOUN
gra-2158	96	2	7	7	NUM
gra-2158	96	3	.	.	PUNCT
gra-2158	96	4	c.	c.	PROPN
gra-2158	96	5	rao	rao	PROPN
gra-2158	96	6	aaf	aaf	PROPN
gra-2158	96	7	.	.	PUNCT
gra-2158	96	8	efcacy	efcacy	NOUN
gra-2158	96	9	and	and	CCONJ
gra-2158	96	10	safety	safety	NOUN
gra-2158	96	11	of	of	ADP
gra-2158	96	12	oral	oral	ADJ
gra-2158	96	13	triple	triple	ADJ
gra-2158	96	14	drug	drug	NOUN
gra-2158	96	15	combination	combination	NOUN
gra-2158	96	16	(	(	PUNCT
gra-2158	96	17	voglibose	voglibose	NOUN
gra-2158	96	18	,	,	PUNCT
gra-2158	96	19	glimepiride	glimepiride	NOUN
gra-2158	96	20	and	and	CCONJ
gra-2158	96	21	metformin	metformin	NOUN
gra-2158	96	22	)	)	PUNCT
gra-2158	96	23	in	in	ADP
gra-2158	96	24	the	the	DET
gra-2158	96	25	management	management	NOUN
gra-2158	96	26	of	of	ADP
gra-2158	96	27	type	type	NOUN
gra-2158	96	28	2	2	NUM
gra-2158	96	29	diabetes	diabetes	NOUN
gra-2158	96	30	mellitus	mellitus	NOUN
gra-2158	96	31	.	.	PUNCT
gra-2158	97	1	int	int	PROPN
gra-2158	98	1	j	j	PROPN
gra-2158	98	2	curr	curr	PROPN
gra-2158	98	3	res	res	PROPN
gra-2158	98	4	rev	rev	PROPN
gra-2158	98	5	.	.	PUNCT
gra-2158	99	1	2013;5(16):20	2013;5(16):20	NUM
gra-2158	99	2	-	-	SYM
gra-2158	99	3	26	26	NUM
gra-2158	99	4	.	.	NOUN
gra-2158	99	5	8	8	NUM
gra-2158	99	6	.	.	X
gra-2158	99	7	ghadge	ghadge	VERB
gra-2158	99	8	aa	aa	NOUN
gra-2158	99	9	,	,	PUNCT
gra-2158	99	10	kuvalekar	kuvalekar	NOUN
gra-2158	99	11	aa	aa	PROPN
gra-2158	99	12	.	.	PUNCT
gra-2158	100	1	controversy	controversy	NOUN
gra-2158	100	2	of	of	ADP
gra-2158	100	3	oral	oral	ADJ
gra-2158	100	4	hypoglycemic	hypoglycemic	ADJ
gra-2158	100	5	agents	agent	NOUN
gra-2158	100	6	in	in	ADP
gra-2158	100	7	type	type	NOUN
gra-2158	100	8	2	2	NUM
gra-2158	100	9	diabetes	diabetes	NOUN
gra-2158	100	10	mellitus	mellitus	NOUN
gra-2158	100	11	:	:	PUNCT
gra-2158	100	12	novel	novel	ADJ
gra-2158	100	13	move	move	NOUN
gra-2158	100	14	towards	towards	ADP
gra-2158	100	15	combination	combination	NOUN
gra-2158	100	16	therapies	therapy	NOUN
gra-2158	100	17	.	.	PUNCT
gra-2158	101	1	diabetes	diabetes	NOUN
gra-2158	101	2	metab	metab	ADJ
gra-2158	101	3	syndr	syndr	PROPN
gra-2158	101	4	clin	clin	PROPN
gra-2158	101	5	res	res	PROPN
gra-2158	101	6	rev	rev	PROPN
gra-2158	101	7	.	.	PUNCT
gra-2158	102	1	2017;11	2017;11	NUM
gra-2158	102	2	:	:	PUNCT
gra-2158	102	3	s5	s5	NOUN
gra-2158	102	4	-	-	NOUN
gra-2158	102	5	s13	s13	NOUN
gra-2158	102	6	.	.	PUNCT
gra-2158	103	1	doi:10.1016	doi:10.1016	PROPN
gra-2158	103	2	/	/	SYM
gra-2158	103	3	j.dsx.2016.08.009	j.dsx.2016.08.009	PROPN
gra-2158	103	4	9	9	NUM
gra-2158	103	5	.	.	PUNCT
gra-2158	104	1	oh	oh	NUM
gra-2158	104	2	tj	tj	PROPN
gra-2158	104	3	,	,	PUNCT
gra-2158	104	4	yu	yu	PROPN
gra-2158	104	5	jm	jm	PROPN
gra-2158	104	6	,	,	PUNCT
gra-2158	104	7	min	min	PROPN
gra-2158	104	8	kw	kw	PROPN
gra-2158	104	9	,	,	PUNCT
gra-2158	104	10	et	et	PROPN
gra-2158	104	11	al	al	PROPN
gra-2158	104	12	.	.	PROPN
gra-2158	104	13	efcacy	efcacy	NOUN
gra-2158	104	14	and	and	CCONJ
gra-2158	104	15	safety	safety	NOUN
gra-2158	104	16	of	of	ADP
gra-2158	104	17	voglibose	voglibose	NOUN
gra-2158	104	18	plus	plus	CCONJ
gra-2158	104	19	metformin	metformin	NOUN
gra-2158	104	20	in	in	ADP
gra-2158	104	21	patients	patient	NOUN
gra-2158	104	22	with	with	ADP
gra-2158	104	23	type	type	NOUN
gra-2158	104	24	2	2	NUM
gra-2158	104	25	diabetes	diabetes	NOUN
gra-2158	104	26	mellitus	mellitus	NOUN
gra-2158	104	27	:	:	PUNCT
gra-2158	104	28	a	a	DET
gra-2158	104	29	randomized	randomized	ADJ
gra-2158	104	30	controlled	control	VERB
gra-2158	104	31	trial	trial	NOUN
gra-2158	104	32	.	.	PUNCT
gra-2158	105	1	diabetes	diabete	VERB
gra-2158	105	2	metab	metab	PROPN
gra-2158	105	3	j.	j.	PROPN
gra-2158	105	4	2019;43(3):276	2019;43(3):276	PROPN
gra-2158	105	5	-	-	PUNCT
gra-2158	105	6	286	286	NUM
gra-2158	105	7	.	.	PUNCT
gra-2158	106	1	doi:10.4093	doi:10.4093	NOUN
gra-2158	106	2	/	/	SYM
gra-2158	106	3	dmj.2018.0051	dmj.2018.0051	ADJ
gra-2158	106	4	10	10	NUM
gra-2158	106	5	.	.	PUNCT
gra-2158	107	1	faruqui	faruqui	NOUN
gra-2158	107	2	aa	aa	PROPN
gra-2158	107	3	.	.	PUNCT
gra-2158	108	1	safety	safety	NOUN
gra-2158	108	2	and	and	CCONJ
gra-2158	108	3	efcacy	efcacy	NOUN
gra-2158	108	4	of	of	ADP
gra-2158	108	5	fixed	fix	VERB
gra-2158	108	6	dose	dose	NOUN
gra-2158	108	7	combination	combination	NOUN
gra-2158	108	8	of	of	ADP
gra-2158	108	9	voglibose	voglibose	NOUN
gra-2158	108	10	,	,	PUNCT
gra-2158	108	11	glimepiride	glimepiride	NOUN
gra-2158	108	12	and	and	CCONJ
gra-2158	108	13	metformin	metformin	NOUN
gra-2158	108	14	in	in	ADP
gra-2158	108	15	indian	indian	ADJ
gra-2158	108	16	type	type	NOUN
gra-2158	108	17	2	2	NUM
gra-2158	108	18	diabetes	diabetes	NOUN
gra-2158	108	19	mellitus	mellitus	NOUN
gra-2158	108	20	patients	patient	NOUN
gra-2158	108	21	.	.	PUNCT
gra-2158	109	1	adv	adv	PROPN
gra-2158	109	2	diabetes	diabete	VERB
gra-2158	109	3	metab	metab	NOUN
gra-2158	109	4	.	.	PUNCT
gra-2158	110	1	2016;4(3):49	2016;4(3):49	NUM
gra-2158	110	2	-	-	SYM
gra-2158	110	3	54	54	NUM
gra-2158	110	4	.	.	PUNCT
gra-2158	110	5	doi:10.13189	doi:10.13189	PROPN
gra-2158	110	6	/	/	SYM
gra-2158	110	7	adm.2016.040302	adm.2016.040302	PROPN
gra-2158	110	8	x	x	SYM
gra-2158	110	9	43gjra	43gjra	PROPN
gra-2158	110	10	global	global	ADJ
gra-2158	110	11	journal	journal	PROPN
gra-2158	110	12	for	for	ADP
gra-2158	110	13	research	research	NOUN
gra-2158	110	14	analysis	analysis	NOUN
gra-2158	110	15	volume-9	volume-9	NUM
gra-2158	110	16	,	,	PUNCT
gra-2158	110	17	issue-3	issue-3	NUM
gra-2158	110	18	,	,	PUNCT
gra-2158	110	19	march-2020	march-2020	ADJ
gra-2158	110	20	•	•	NOUN
gra-2158	110	21	print	print	NOUN
gra-2158	110	22	issn	issn	PROPN
gra-2158	110	23	no	no	NOUN
gra-2158	110	24	.	.	PROPN
gra-2158	110	25	2277	2277	NUM
gra-2158	110	26	8160	8160	NUM
gra-2158	110	27	•	•	NOUN
gra-2158	110	28	doi	doi	NOUN
gra-2158	110	29	:	:	PUNCT
gra-2158	110	30	10.36106	10.36106	NUM
gra-2158	110	31	/	/	SYM
gra-2158	110	32	gjra	gjra	NOUN